Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hank, BBW>AX? BBWPF sold and became IFGNF which is now sold to Spanish firm for .62..............Need to figure out my cost bases.
Do you know at what price IFGNF was worth when it became new symbol, Etrade will not help as records only 7 years worth . Thanks.
Empire Industries Reports First Quarter 2015 Results
WINNIPEG, MANITOBA--(Marketwired - May 25, 2015) - Empire Industries Ltd. (TSX VENTURE:EIL) today reported its unaudited consolidated financial results for the first quarter ended March 31, 2015. The unaudited consolidated financial statements and MD&A have been filed on SEDAR and can be viewed at www.sedar.com or at www.empind.com.
Summary of the First Quarter 2015 results
•Revenues decreased by $0.5 million, or 1.5% (to $33.2 million from $33.7 million in first quarter 2014)
•Adjusted EBITDA decreased by $0.9 million, or 36% (to $1.5 million from $2.4 million in first quarter 2014)
•Net Loss, after taking into consideration an unrealized loss on forward foreign exchange contracts of $1.9 million, was $0.9 million, versus net income of $1.2 million in first quarter 2014
•The non-cash unrealized foreign exchange loss of $1.9 million in the quarter compares to a loss of $0.6 million in the comparative period relating to outstanding forward foreign currency instruments. This loss resulted from the significant decline of the Canadian dollar incurred during the period as compared to the rates negotiated in the underlying contracts.
•Net Loss was $0.003 per share, versus net income per share of $0.005 in first quarter 2014
•Backlog of $195 million at March 31, 2015, up from $155 million at December 31, 2014
For the quarter and year ended March 31
Q1 Q1
($millions except share price and per share amounts) 2015 2014
Financial Results
Revenue 33.2 33.7
Adjusted EBITDA ($)1 1.5 2.4
Net income (loss) from all operations, after unrealized foreign exchange loss of ($1.9 million; $0.6 in 1st quarter 2014) (0.9 ) 1.2
Financial Position (at March 31)
Total assets 74.5 49.3
Long-term debt (including current portion) 2.9 3.5
Shareholders' equity 21.1 16.6
Per Share Information
Income per share (Basic) $ (0.003 ) $ 0.005
Income per share (Diluted) $ (0.003 ) $ 0.005
1 Adjusted earnings (loss) before interest, tax, depreciation and amortization (Adjusted EBITDA) is not defined by IFRS. The definition of Adjusted EBITDA does not take into account the Group's share of profit of an associate investment, gains and losses on the disposal of assets, fair value changes in foreign currency forward contracts and non-cash components of stock based compensation. While not IFRS measures, Adjusted EBITDA is used by management, creditors, analysts, investors and other financial stakeholders to assess the Group's performance and management from a financial and operational perspective.
"The first quarter was negatively influenced by tighter margins on steel fabrication work and lower sales of hydrovac trucks both of which are reflective of a challenging economic environment in Alberta. The Media Based Attractions had a good quarter, and was similar to the first quarter of 2014," said Guy Nelson, CEO. " I expect our Media Based Attractions to continue to strengthen as we work through our record backlog and to offset the headwinds we expect to continue to feel in our domestic businesses operating in Alberta."
About Empire Industries Ltd.
Empire Industries Ltd. manufactures specialized engineered products and sells these products domestically and in select international export markets. The company has developed, designed and engineered products for the rapidly growing, global, media based attractions market. The company also manufactures and sells hydrovac trucks and provides steel fabrication & installation services, primarily to the industrial, commercial and infrastructure market in Western Canada. The company also has two key strategic equity partnerships; a 49% ownership of ACE Industrial Services that operates in the oil sands industrial maintenance services market, and a 45% ownership of a Chinese joint venture company in the steel fabrication market in Asia. Empire's common shares are listed on the TSX Venture Exchange under the symbol EIL.
For more information about the Company, visit www.empind.com.
Reader Advisory
This news release contains forward-looking statements, within the meaning of applicable securities legislation, concerning Empire's business and affairs. In certain cases, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". These forward looking statements are based on current expectations, and are naturally subject to uncertainty and changes in circumstances that may cause actual results to differ materially. Readers are cautioned not to place undue reliance on such forward-looking statements. Forward-looking information is provided as of the date of this press release, and Empire assumes no obligation to update or revise them to reflect new events or circumstances, except as may be required under applicable securities laws. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact:
Empire Industries Ltd.
Guy Nelson
Executive Chairman & CEO
(416) 366-7977
gnelson@empind.com
Empire Industries Ltd.
Allan Francis
VP Corporate Affairs & Administration
(204) 589-9301
afrancis@empind.com
AMPG - AmpliTech Group Reports First Quarter Profit
NEW YORK, May 20, 2015 /PRNewswire/ -- AmpliTech Group, Inc. (OTC-QB: AMPG) filed their 10-Q for the first quarter of 2015. CEO Fawad Maqbool stated, "AmpliTech Group has been following a path towards reducing its debt and operating expenses as well as increasing its bookings and revenue. We have taken great strides towards our goals as stated in our previous press releases and I am pleased to report the highlights of those advances below."
Net consolidated profit and EBITDA of $48,000 vs. net loss of $82,000 in 1Q 2014
Increase in revenue by 7% vs. 1Q 2014's revenue
Decrease in Cost of Goods (COGS) by 16%
Increase in gross profit by 34%
Minimal payables and no convertible or long term debt
Reduction of interest expense
Reduction of overall liabilities by 17%
Mr. Maqbool also stated, "It is evident that the company has 'turned the corner' as shown by its overall performance and growth this year. Our bookings have been increasing so we expect that we can sustain this performance with increased profitability for the rest of the year. We further anticipate that our new product development and planned joint ventures will also help to keep us on the path to growth and technical excellence."
About AmpliTech Group, Inc.
AmpliTech Group, Inc. designs, develops, and manufactures custom and standard state-of-the-art RF components for the Domestic and International, SATCOM, Space, and Military markets. These designs cover the frequency range from 50 kHz to 40 GHz - eventually, offering designs up to 100 GHz. AmpliTech also provides consulting services to help with any microwave components or systems design problems. Our steady growth over the past 13+ years has come about because we can provide complex, custom solutions for nearly ANY custom requirements that are presented us. In addition, we have the best assemblers, wires, and technicians in the industry and can provide contract assembly of customers' own designs. Click here to view AmpliTech video. Website: http://www.AmpliTechinc.com
http://www.prnewswire.com/news-releases/amplitech-group-reports-first-quarter-profit-300086307.html
KLYG.. $0.0899.. Update.. I went to see them earlier this week and I was at first after getting off I-84 by my GPS sent thru the very bowels of Hartford CT which demonstrates the value of Democratic control and decay of the Insurance capitol of the US..
But shortly I drove westerly thru prosperous communities of CT I never knew existed.. Shortly I was in Canton and drove Into a well kept Industrial Park where KLYG has it's office and manufacturing facilities..
There I was greeted by management and was demonstrated what they do.. They are a Medical Device manufacturing Company that specializes in the production of customized implants utilizing computer aided design and advanced bio-compatible medical grade polymers...
That description was taken from the back of their brochure
My take was they were a well oiled machine run financially buy a money pinching Scottsman that was in charge,, having really no knowledge about what it is/or what is the definition of being public..
Most investment inquiry calls to them come from NY types telling them they will take their stock to the moon and all they need to do so is a retainer for their efforts.. They all almost gtd. to place KLYG in front of the most influential and important people in the financial and just give us a try for 3 to 6 months with a retainer of $3 to $6K for the ride.. KLYG traded 1600 shares today for the first time in a month..
Once they realized I was not a PR type and actually owned stock we took a tour.. The company is compactly laid out in a spotless 5,000 sq. ft. facility that is 65% working areas and 35% office, entry and conference room areas.. All were clean and functional..
KLYG receives orders usually from hospitals with PO's attached
to create implants for cranial damage, or bone diseases in the skull and can do so with a 24 hour turn around.. Sales are constant and this past year KLYG is profitable for the first time.. Next year KLYG benefits from the removal of the OBAMA Medical Devices Tax which is on Gross sales and could bring an additional 35% to 50% Pre tax to their bottom line..
Their facilities are centered around a gang of C&C machines working in dust free and contamination free areas producing orders with FDA approval on an almost daily basis.. Staff is small and I believe I counted 6 plus a management of 3.. Their sales are either direct or obtained thru reps calling on hospitals thru out the US also handling/selling other Medical devices..
My main concern for going because of my position in the company and the lack of volume in the stock along with the filings being over due.. I was some what surprise that management was unaware that this was not being done and assured me that they would take care of it shortly..
I think since they were brought in to take charge of a company built by promoters using PR's to sell stock rather than run a company that they bought to promote the stock.. I believe present management when they said they thought they were being filed by someone else.. They have increase sales each year and this was their first profitable year. Shares are at $2,000,000 dollar level and that is a guess by me. Shares out are a little above 23 million and have not been increased since the new management took over..
I will try to help them get thru this period of becoming aware of being public but will accept fee or stock for compensation.. All the shares I own have been paid for with my own funds.. I will be a bid buyer so you guys do what you want.. Remember this is a LT stock but I think there is also a possible that it could be bought out in the future.. It has only traded 16000 shares during the past month so what you buy is what you own.. hank
Any thoughts on this one?
Slow day,, it's time to go play with the cars.. hank
AMEH... $0.51.. Looks like it's becoming a large company but,, will it ever make money..??? New PR firm re4ally doesn't really get me exicted....
Apollo Medical Holdings Announces Expansion of Hospitalist and Post-Acute Care Services to the San Francisco Bay Area
GLENDALE, Calif., March 16, 2015 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed") (OTC-QB: AMEH), an integrated patient-centered, physician-centric healthcare delivery company, today announced the expansion of its hospitalist and post-acute care services to the San Francisco Bay Area.
The practice, operated through one of ApolloMed's affiliated medical groups, is expected to represent an annualized volume of approximately 42,000 patient encounters and will include both hospitalist and post-acute care services. ApolloMed already has an established presence in the Bay Area through its Accountable Care Organization (ACO).
"We are very pleased to expand our presence in the Bay Area," stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings. "We will continue to strive to achieve our goals of growth and to partner with new hospitals, health plans, nursing homes and physicians. Our strategy is to expand not only in California but also in select markets throughout the U.S."
About Apollo Medical Holdings, Inc.
ApolloMed is a leading integrated patient-centered, physician-centric healthcare delivery company committed to providing exceptional multi-disciplinary care in the communities it serves. ApolloMed is addressing the healthcare needs of its patients by leveraging its integrated healthcare delivery platform comprised of six affiliated and complementary physician groups: ApolloMed Hospitalists, ApolloMed ACO (Accountable Care Organization), Maverick Medical Group (Independent Physician Association), AKM Medical Group (IPA), ApolloMed Care Clinics and Apollo Palliative Services. ApolloMed strives to improve medical outcomes with high-quality, cost-efficient care. For more information, please visit www.apollomed.net.
Forward Looking Statements
This press release may contain forward-looking statements, including information about management's view of future expectations, plans and prospects for Apollo Medical Holdings, Inc. ("the Company"). In particular, when used in the preceding discussion, where we refer to quarter over quarter revenue growth targeted for the remainder of 2014 and the words "predicts," "believes," "expects," "intends," "seeks," "estimates," "plans," "anticipates," and similar conditional expressions or future or conditional verbs such as "will," "may," "might," "should," "would" and "could" are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development, are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company's management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance or achievements of the Company, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance or achievements may vary materially from those described in the relevant forward-looking statement as being expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company's future results. The forward-looking statements included herein are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under Item 1A. "Risk Factors" of the Company's Annual Report on Form 10-K for the year ended January 31, 2014 and in any of the Company's other subsequent Securities and Exchange Commission filings.
FOR MORE INFORMATION PLEASE CONTACT:
Michael Sullivan
RedChip Companies Inc.
1-800-733-2447, ext. 115
sully@redchip.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/apollo-medical-holdings-announces-expansion-of-hospitalist-and-post-acute-care-services-to-the-san-francisco-bay-area-300050776.html
SOURCE Apollo Medical Holdings, Inc.
RNWEY.. Something some may find interesting..
TOP 20 SHAREHOLDERS AT PRESENT OF RECORD.....
Investor Number of shares % of total Type
Country
UMOE AS 496,872,361 21.47% Comp. NOR
FOLKETRYGDFONDET 122,651,917 5.30% Comp. NOR
SKAGEN KON-TIKI 83,201,594 3.60% Comp. NOR
PICTET & CIE (EUROPE) S.A. 70,435,424 3.04% Nom. LUX
EQUITY TRI-PARTY (3) 70,014,606 3.03% Comp. GBR
CLEARSTREAM BANKING S.A. 50,699,726 2.19% Nom. LUX
STATE STREET BANK & TRUST COMPANY 49,041,359 2.12% Nom. USA
JP MORGAN CHASE BANK, NA 33,940,000 1.47% Nom. SWE
SKAGEN VEKST 29,162,486 1.26% Comp. NOR
EUROCLEAR BANK S.A./N.V. ('BA') 27,081,868 1.17% Nom. BEL
JPMORGAN CHASE BANK, N.A 24,990,228 1.08% Nom. GBR
VERDIPAPIRFONDET DNB NORGE (IV) 21,370,374 0.92% Comp. NOR
SWEDBANK GENERATOR 20,956,649 0.91% Comp. NOR
L-INVEST AS 20,000,000 0.86% Comp. NOR
UBS AG, LONDON BRANCH 19,472,777 0.84% Nom. GBR
STATOIL PENSJON 19,111,102 0.83% Comp. NOR
THE BANK OF NEW YORK MELLON SA/NV 18,539,684 0.80% Nom. GBR
FONDSFINANS SPAR 17,000,000 0.73% Comp. NOR
J.P. MORGAN CHASE BANK N.A. LONDON 16,475,902 0.71% Nom. USA
UBS AG 16,411,796 0.71% Nom. CHE
Total number owned by top 20
1,227,429,853
53.05%
Total number of shares
2,313,818,785
100%
Last updated 09.03.2015
RNWEY $0.11... ANY THOUGHTS,, $0.10 in EPS for 6 mo's.
==================================================================
10 bagger Member Level Monday, 02/16/15 12:52:26 PM
Re: 10 bagger post# 164379
Post # of 165581
RNWEY.. $O.1028 BID.. earnings.. $0.05 EARNINGS NOW BACK TO BACK FOR THE 4'TH QTR..Listed on the Oslo Stock
Exchange (ticker: REC), the company is headquartered in Moses Lake, Washington
and employs 720 people.
Fornebu, February 13, 2015: REC Silicon ASA reported fourth quarter 2014
revenues of USD 126.2 million compared to USD 126.5 million in the third
quarter. Higher polysilicon sales volumes were offset by lower polysilicon
prices and decreased sales volumes of silicon gases.
EBITDA for the fourth quarter was USD 38.0 million. Third quarter EBITDA
included the recognition of USD 101 million associated with the transfer of
technology to the Yulin JV. The underlying comparable EBITDA decreased by
approximately 17 percent compared to the prior quarter, primarily due to lower
polysilicon prices.
The polysilicon and silane gas loading expansion projects at Moses Lake and
Butte are proceeding according to schedule. Building permits have been obtained
and construction activity has commenced. The Yulin Joint Venture is also
progressing according to plan. The contract on detailed engineering has been
awarded and the work has commenced. REC Silicon made the first capital
contribution of USD 75 million to the JV in October 2014.
"Continued focus on efficient and stable operations resulted in record high
production volumes and secured REC Silicon's competitive cost position.
Although challenging market dynamics and the uncertainty created by the US/China
trade dispute led to pressure on solar grade polysilicon prices during the
quarter, REC Silicon's financials remain strong," commented Tore Torvund, CEO of
REC Silicon.
Net financial items resulted in income of USD 112.8 million, mainly reflecting
net currency gains, and fair value adjustment of convertible bonds offset by
interest expense.
Profit from continuing operations was USD 119.0 million in the fourth quarter,
compared to USD 119.5 million in the previous quarter.
Basic and diluted EPS from total operations was USD 0.05 in the fourth quarter
2014, unchanged from the previous quarter.
For more information, please see the attached fourth quarter 2014 report.
Morning program:
The Company will give a presentation at 08:00 a.m. CET today at
Konferansesenteret Høyres Hus, Stortingsgaten 20, 0117 Oslo, Norway. The
presentation will be held in English.
There will be a live webcast from the presentation which can be accessed from:
www.recsilicon.com.
It will also be possible to listen to the presentation through a conference
call. Please make sure to dial in 10 minutes prior to scheduled start time on
one of the following numbers:
Norway: +47 23 50 04 86
UK: +44 (0)20 3427 1909
USA: +1 212 444 0412
International Toll: +44 (0)20 3427 1909
Please provide confirmation code 7022732 and state your name, company and
country of residence.
Afternoon program:
REC Silicon will host an analyst conference call with possibilities for
questions and answers later the same day at 3:00 p.m. CET. Please make sure to
dial in at least five minutes ahead of time to complete your registration.
International dial in: +47 23 50 04 86
Please provide confirmation code 1521035 and state your name, company and
country of residence.
For further information, please contact:
Mitra H. Negård, Investor Relations
REC Silicon ASA
Phone: +47 957 93 631
Email: mitra.negard@recsilicon.com
==============================================================
About REC Silicon
REC Silicon is a leading producer of advanced silicon materials, delivering
high-purity polysilicon and silicon gas to the solar and electronics industries
worldwide. We combine 25 years of experience and proprietary technology with the
needs of our customers, and annual production capacity of more than 20,000 MT of
polysilicon from our two US-based manufacturing plants. Listed on the Oslo Stock
Exchange (ticker: REC), the company is headquartered in Moses Lake, Washington
and employs 720 people.
For more information: www.recsilicon.com
This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)
=====================================================
10 bagger Member Level Tuesday, 11/11/14 01:41:10 PM
Re: 10 bagger post# 5211
Post # of 5255
RNWEY.. $0.1528...
Quote:
The company is headquartered in Moses Lake, Washington and employs 710 people.
For more information, go to: www.recsilicon.com
Fornebu, November 4, 2014: REC Silicon ASA reported third quarter 2014 revenues of USD 126.5 million and EBITDA excluding special items from continuing operations of USD 44.9 million. In addition, the Company recognized special items of USD 101 million related to the sale of its silane based FBR-B technology to the joint venture in China. REC Silicon ASA reported total EBITDA of USD 145.9 million.
Debt has been reduced by USD 55 million to USD 228 million, primarily due to the repayment of an NOK 196 million bond (REC01).
REC Silicon Segment reported third quarter revenues of USD 126.5 million, compared to USD 126.8 million in the previous quarter. Lower polysilicon sales volumes were offset by record silicon gas sales volumes and resulted in revenues broadly in line with the previous quarter. The corresponding EBITDA excluding special items during the third quarter was USD 45.5 million compared to USD 33.1 million in the previous quarter. The increased EBITDA can be attributed primarily to lower costs driven by stable operations and high production levels.
The Segment also reported record silicon gas sales volumes. Sales volumes were driven by a combination of improved end use demand and by competitive capacity being offline.
The Company is announcing a 3,000 MT granular polysilicon expansion at its Moses Lake facility and an agreement to investigate the development of a 20,000 MT granular polysilicon plant in Saudi Arabia.
Additionally, the Company reported the receipt of the final technology transfer payment of USD 99 million from the Joint Venture in China. Front End Engineering Design (FEED) has been delivered and the project has relocated to China to begin detailed engineering.
"Increased EBITDA in the third quarter is primarily the result of stable operations and continued focus on production efficiency. The results demonstrate the value of REC Silicon's superior FBR technology," commented Tore Torvund, CEO of REC Silicon. "I am pleased that our FBR technology is being recognized as the leading polysilicon manufacturing technology which has resulted in the announcement to expand our Moses Lake facility, the Yulin JV in China, and a potential expansion in Saudi Arabia."
Net financial items resulted in income of USD 45.7 million, mainly reflecting net currency gains, and fair value adjustment of convertible bonds offset by interest expense.
Profit from continuing operations was USD 119.5 million in the third quarter, compared to USD 24.6 million in the previous quarter. The improved result mainly reflects higher EBITDA, special items, and positive net financial items.
Basic and diluted EPS from total operations was USD 0.05 in the third quarter 2014, compared to USD 0.01 in the previous quarter.
For more information, please see the attached third quarter 2014 report.
Morning program:
The Company will give a presentation at 08:00 a.m. CET today at Konferansesenteret Høyres Hus, Stortingsgaten 20, 0117 Oslo, Norway. The presentation will be held in English.
There will be a live webcast from the presentation which can be accessed from: www.recsilicon.com.
It will also be possible to listen to the presentation through a conference call. Please make sure to dial in 10 minutes prior to scheduled start time on one of the following numbers:
Norway Toll Free: 800 56 054
UK Toll Free: 0800 279 5004
USA Toll Free: 1 877 280 2296
International Toll: +44 (0)20 3427 1915
Please provide confirmation code 5650922 and state your name, company and country of residence.
Afternoon program:
REC Silicon will host an analyst conference call with possibilities for questions and answers later the same day at 3:00 p.m. CET. Please make sure to dial in at least five minutes ahead of time to complete your registration.
International dial in: +47 2316 2729
Please provide confirmation code 1513752 and state your name, company and country of residence.
For further information, please contact:
Mitra H. Negård, Investor Relations
REC Silicon ASA
Phone: +47 957 93 631
Email: mitra.negard@recsilicon.com
About REC Silicon
REC Silicon is a leading producer of advanced silicon materials, delivering high-purity polysilicon and silicon gas to the solar and electronics industries worldwide. We combine 25 years of experience and proprietary technology with the needs of our customers, and annual production capacity of more than 20,000 MT of polysilicon from our two US-based manufacturing plants. Listed on the Oslo Stock Exchange (ticker: REC), the company is headquartered in Moses Lake, Washington and employs 710 people.
For more information, go to: www.recsilicon.com
=========================================================
Monday, 10/13/14 03:59:41 PM
Re: 10 bagger post# 5092
Post # of 5255
RNWEY.. $0.11 Bid,, $0.19 offered.. , July 18, 2014:
Quote:
The profit from continuing operations was USD 24.6 million in the second quarter, compared to a loss of USD 49.7 million in the previous quarter. The improved result mainly reflects higher EBITDA and positive net financial items.
REC Silicon ASA reported second quarter 2014 revenues of USD 126.9 million and EBITDA from continuing operations of USD 31.6 million. Debt has been reduced by USD 125 million to USD 283 million, primarily due to the repayment of the Euro 81 million convertible bond.
REC Silicon Segment reported second quarter revenues of USD 126.8 million, compared to USD 113.3 million in the previous quarter. The corresponding EBITDA during the second quarter was USD 33.1 million compared to USD 19.5 million in the previous quarter. The increased EBITDA can be attributed to higher sales volumes and selling prices partially offset by higher manufacturing costs.
Higher average polysilicon prices reflect continued strong demand for solar grade polysilicon and increasing acceptance of granular polysilicon by the market.
Silicon gas sales volumes continued to be strong. Sales were driven by a combination of improved Photovoltaic, Flat Panel Display, and Semiconductor demand and by competitive capacity being currently offline.
"Strong second quarter EBITDA demonstrates the strengthening demand for granular polysilicon and silicon gases in the market" commented Tore Torvund, CEO of REC Silicon. "During the quarter, we successfully completed the five year inspection program in Silane III. Although these outages resulted in higher cost during the first half of 2014, we have completed the planned outages and will operate at full capacity for the remainder of the year."
Net financial items were an income of USD 21.4 million, mainly reflecting net currency gains, and fair value adjustment of convertible bonds offset by interest expense.
The profit from continuing operations was USD 24.6 million in the second quarter, compared to a loss of USD 49.7 million in the previous quarter. The improved result mainly reflects higher EBITDA and positive net financial items.
Basic and diluted EPS from total operations was USD 0.01 in the second quarter 2014, compared to USD -0.02 in the previous quarter.
For more information, please see the attached second quarter 2014 report.
http://www.recsilicon.com/investors/
DGPIF.. $0.62... DATA Group earned net income of $4.5 million or $0.19 per share in the year ended December 31, 2014 versus a loss in the prior year
$DGPIF Data Group #Canadian $DGI..Q4 2014
• Fourth quarter 2014 (“Q4”) Revenues of $80.4 million, Q4 Gross Profit of $18.7 million and Q4 Net Income of $1.6 million
• Q4 Adjusted EBITDA of $6.2 million (See Table 2 and “Non-GAAP Measures” below)
2014
• 2014 (“YTD”) Revenues of $313.2 million, YTD Gross Profit of $74.6 million and YTD Net Income of $4.5 million
• YTD Adjusted EBITDA of $22.5 million (See Table 2 and “Non-GAAP Measures” below)
Brampton, Ontario – March 5, 2015 – DATA Group Ltd. (TSX: DGI) (“DATA Group”) announced its consolidated financial and
operating results for the fourth quarter and the year ended December 31, 2014.
DATA Group earned net income of $4.5 million or $0.19 per share in the year ended December 31, 2014 versus a loss in
the prior year. DATA Group is encouraged by its results in the second half of 2014 as revenue increased by 1.4% and Adjusted
EBITDA stabilized compared to the same period in 2013.
Debt Reduction
During the year, DATA Group repaid $6.5 million of debt, bringing its total debt including its convertible debentures to $90.1 million.
During the fourth quarter, we extended the term of our senior debt credit facilities to August 31, 2016.
Revenue Stabilization/Growth
Our intent in 2014 was to stabilize our revenue and position ourselves for longer term revenue growth. During 2014, DATA Group
had revenues of $313.2 million, a 1.2% decline from 2013. Our revenues included strong growth from our U.S. customers. During
the second half of 2014 overall revenue grew by 1.4% compared to the same period in 2013. We continue with our plans to;
• Add new sales talent
• Win market share in our traditional print business
• Invest in the key growth areas we have identified; labels, marketing print and digital communications
• Bundling our digital services with our print offerings
• Expand our U.S. revenue
More...
http://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00032678
1c
MNDO.. $3.85 to $4.02.. Sold out of my position yesterday.. I think it's wash and rinse for the second time.. hank..
EIL.v /erlif +.025 to C$.12
http://finance.yahoo.com/news/empire-industries-reports-two-contract-120000217.html
$42 million in new contracts in addition to last week's $24 million!
Thanks to KIK
OT: solid article on microcap investing...
http://www.tarsiercm.com/wp-content/uploads/2014/12/Micro-Cap-Advantages-White-Paper.pdf
AMPG.. $0.021.. AmpliTech Receives Over $400,000 in New Orders
BOHEMIA, N.Y., March 3, 2015 (GLOBE NEWSWIRE) -- AmpliTech Group, Inc. (AMPG) announced today that it has received new orders valued at over $400,000 from international government and domestic private customers within the last 2 months. These new orders are for products for which AmpliTech has primarily been a sole source due to its unique and unparalleled performance attributes that have made AmpliTech the number one choice for our customers worldwide. These initial new orders are expected to position AmpliTech on long term supply chain roadmaps to provide its innovative and high performance products and solutions to mission critical programs.
CEO Fawad Maqbool stated, "AmpliTech's core product line is a perfect lead-in for the company in pursuit of its strategic objectives for large scale commercialization of its innovative technologies to drive the new product pipeline currently in the development for its newly formed Wireless Solutions Group. Clearly, what we are seeing is that the demand for our products is on the rise and is expected to substantially increase as we move forward with the transition into mass markets in line with our company strategy and vision as stated in previous press releases. We anticipate the increase in our bookings and backlog to continue throughout the remainder of the year as we move forward with our initiatives to shape the future of AmpliTech product offerings."
About AmpliTech Group, Inc.
AmpliTech Group, Inc. is an innovative provider of advanced radio frequency technology solutions serving applications from 50 kHz to 100 GHz across a diverse mix of markets. AmpliTech designs, develops, and manufactures custom and standard state-of-the-art RF and microwave and millimeter-wave components and integrated modules for the Domestic and International, SATCOM, Space, wireless infrastructure, test & measurement, and Military markets. In addition to our product offerings we leverage our design and product development expertise and core competencies to provide consulting and manufacturing services to our customers helping them reduce design cycle time and cost, achieve faster time to market, and lower manufacturing costs. Our steady growth over the past 13+ years has been the result of our commitment to not only meet, but to exceed the rigorous performance, quality, and reliability requirements of our diverse mix of customers. Click here to view AmpliTech video. Website: http://www.AmpliTechinc.com
Forward-looking Statements
This release contains statements that constitute forward-looking statements. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company's financing plans; (ii) trends affecting the Company's financial condition or results of operations; (iii) the Company's growth strategy and operating strategy. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.
View photo
.
Contact:
Fawad Maqbool, CEO
AmpliTech Group, Inc.
(631) 521-7831
NGHT $0.029... I have been looking at NGHT for some time and I think there is value there.. I'm not crazy about the share structure or the possibility of more shares outstanding but do believe the concept is viable and more important repeatable..
I am coming to the belief that if they present ,, those who like an fair type place to gather will come.. I also think that almost every large fair in the US could be a potential for their type of performing with acts already preforming for them BECAUSE A SHOW THAT THEY DON'T HAVE TO BOOK AND GET PAID FOR MAKES SENSE TO MOST COMMUNITY OPERATORS ,, WHO MOST ARE VOLUNTEERS.. Smaller fairs could also become a breeding ground for them to establish new talents..
It took me a while to get the concept but I think I've finally got..
NGHT follower's will make a mistake if they follow because of the results of just one outing and do not look at the total ..
As to the shares ,, I THINK GREED WILL TAKE OF THAT ONCE THE TOTAL COCEPT IS REALIZED.....
MNDO.. WASH AND RINSE..*Board Declares Cash Dividend
Yoqneam, Israel, February 26, 2015 MIND C.T.I. LTD. – (NasdaqGM:MNDO), a leading provider of convergent end-to-end prepaid/postpaid billing and customer care product based solutions for service providers as well as unified communications analytics and call accounting solutions for enterprises, today announced results for the fourth quarter and year ended December 31, 2014.
The following will summarize our business in the fourth quarter of 2014 and provide a more detailed review of the financial results for the quarter. The financial results can be found in the Investors section www.mindcti.com/investor/PressReleases.asp and in our Form 6-K.
Financial Highlights of Q4 2014
· Revenues of close to $6.5 million, same as the third quarter of 2014, and up 28% from $5.1 million in the fourth quarter of 2013.
· Operating income was $2.5 million, up 15% sequentially from the third quarter of 2014 and compared to $1.0 million in the fourth quarter of 2013.
· Net income of $1.9 million or $0.10 per share, compared to $1.0 million or $0.05 per share in the fourth quarter of 2013.
· One modest win and multiple upgrades.
As of December 31, 2014 we had 352 employees, the same as of December 31, 2013.
Year 2014 Financial Highlights
· Revenues of $25 million, up 35% from $18.5 million in 2013.
· Operating income was $7.5 million, or 29.8% of revenue, compared to $2.2 million, or 11.7% of revenue, in 2013.
· Net income of $5.5 million, or $0.29 per share, compared to $2.2 million or $0.12 per share in 2013.
· Cash flow from operating activities was $3.8 million, compared to $5.2 million in 2013.
· Cash position of approximately $19.3 million as of December 31, 2014.
Monica Iancu, CEO, commented: “We are pleased that in 2014 we succeeded to translate the large deals we signed in 2013 into revenues through successful execution of the implementation of our projects milestones. While in 2014 we reached exceptional revenues and operating margins, some new deals that we expected to close in 2014 were delayed, thus our booking is lower than a year ago.”
Revenue Distribution for Q4 2014
Revenues in the Americas represented 54.5% of total revenues, revenues in Europe represented 34.2% and revenues in Israel represented 6.6% of total revenues.
Revenues from our customer care and billing software totaled $5.5 million, or 85% of total revenues, while revenues from our enterprise call accounting software were $1.0 million, or 15% of total revenues.
Revenues from licenses were $1.2 million, or 18% of total revenues, while revenues from maintenance and additional services were $5.3 million, or 82% of total revenues.
Revenue Distribution for Full Year 2014
Revenues in the Americas represented 57.6%, revenues in Europe represented 28.6% and revenues in Israel represented 9.0% of total revenue.
1
Revenues from our customer care and billing software totaled $21.0 million, or 84% of total revenues, compared with $14.2 million, or 77% of total revenues in 2013, while revenues from our enterprise call accounting software were $4.0 million, or 16% of total revenue, compared with $4.3 million or 23% of total revenues in 2013.
Revenues from licenses were $5.4 million, or 21.6% of total revenues, compared with $4.6 million, or 25% of total revenues in 2013 while revenues from maintenance and additional services were $19.6 million, or 78.4%, compared with $13.9 million or 75% of total revenues in 2013.
New Wins & Follow-on Orders in Q4 2014
In the fourth quarter we had one modest new win as well as some major upgrades from existing customers, the upgrades mainly for service enhancements and additional functionalities.
The new win is with a leading European global financial services company. PhonEX-ONE has been chosen for its advanced telecom business analysis and cost control management solution for global organizations.
One major upgrade includes enhancement of the MIND system to distinguish between data services (Internet, MMS, VoLTE), and to authorize and rate these differently. MIND will provide different configurable authorization amounts for “capping” the data services that will be offered by this customer.
Dividend Distribution
Since July 2003, when we first adopted a dividend policy, according to which we declare, subject to specific Board approval and applicable law, a dividend distribution once per year, we have distributed 11 yearly dividends with an average of 21 cents per share.
We continue to believe that our annual dividends enhance shareholders value and we plan to continue with yearly distributions.
Taking into consideration our dividend policy and the remaining cash after the distribution, our Board declared on February 26, 2015 a gross dividend of $0.30 per share. The record date for the dividend will be March 12, 2015 and the payment date will be March 26, 2015. Tax will be withheld at a rate of about 24%.
Investing in R&D
In order to maintain a state-of-the-art technology, each year we invest in R&D, sometimes adding new modules, sometimes in order to be compliant with new standards and many times to keep up with the new tools and new platforms that we use to build upon.
In 2014, along with supporting the additional needs defined by our customers, we invested significantly in a massive upgrade of the MINDBill infrastructure that includes technology updates of the entire spectrum, including application infrastructure, application server and database upgrades and improved monitoring.
New Office in Romania
Lately we started to analyze the option to open a new MIND office location in East Europe in order to enlarge and diversify our teams, mainly in the Professional Services department.
We checked the availability of qualified resources and office space in several locations, and we decided that Suceava, Romania is the preferred location. Our second location in Romania started to operate on February 16, 2015.
Monica concluded: “We are pleased as always with the growing recurring revenues and the follow-on orders that reconfirm our customer satisfaction. We operate in a very active market that shows continuous demand for our products and services and we expect that in 2015 we will be able to close new deals and significant follow-on orders. The valuable customer base, well supported by our devoted professional team and the ongoing investment in development of enhanced functionality and state-of-the-art technology are the basis for our expected long-term continuous performance.”
2
About MIND
MIND CTI Ltd. is a leading provider of convergent end-to-end billing and customer care product based solutions for service providers as well as unified communications analytics and call accounting solutions for enterprises. MIND provides a complete range of billing applications for any business model (license, managed service or complete outsourced billing service) for Wireless, Wireline, Cable, IP Services and Quad-play carriers in more than 40 countries around the world. A global company, with over thirteen years of experience in providing solutions to carriers and enterprises, MIND operates from offices in the United States, Romania and Israel.
Cautionary Statement for Purposes of the "Safe Harbor" Provisions of the Private Securities Litigation Reform Act of 1995: All statements other than historical facts included in the foregoing press release regarding the Company's business strategy are "forward-looking statements." These statements are based on management's beliefs and assumptions and on information currently available to management. Forward-looking statements are not guarantees of future performance, and actual results may materially differ. The forward-looking statements involve risks, uncertainties, and assumptions, including the risks discussed in the Company's filings with the United States Securities Exchange Commission. The Company does not undertake to update any forward-looking information.
For more information please contact:
Andrea Dray
MIND CTI Ltd.
Tel: +972-4-993-6666
investor@mindcti.com
ALQA $5.92..Interesting company added to the watch list.. Price at present is waaay to high for my taste but with all the news out at present lower prices could be ahead.. The current lows of the year could become an initial entry point..
Alliqua BioMedical, Inc. Reports Fourth Quarter and Fiscal Year 2014 Financial Results
GlobeNewswire - Feb 24 07:30 EDT
Alert hits:*me EDG
Company Symbols: NASDAQ-SMALL:ALQA
Updates Fiscal 2015 Revenue Outlook
LANGHORNE, Pa., Feb. 24, 2015 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a provider of advanced wound care products, today announced financial results for the fourth quarter and fiscal year ended December 31, 2014.
Q4 Highlights:
Total revenue increased 255% year-over-year to approximately $1.7 million. Organic revenue growth was 128% year-over-year.
Proprietary products revenue increased 1,170% year-over-year to approximately $1.3 million. Organic product revenue growth was 609% year-over-year.
On November 3rd, the Company announced Alliqua's Biovance® Human Amniotic Membrane Allograft has been assigned a new and unique, Level II Healthcare Common Procedure Coding System (HCPCS) product reimbursement Q code (Q4154) by the Centers for Medicare and Medicaid Services ("CMS"). This decision was a significant step towards obtaining comprehensive coverage reimbursement coverage for Biovance in the outpatient setting.
Highlights Subsequent to Quarter-End:
On January 5th, the Company announced a Group Purchasing Agreement with Premier, Inc.
On February 2nd, the Company announced a definitive agreement to acquire Celleration, Inc. for an initial purchase price of approximately $30.4 million, which is comprised of both cash and stock.
"Our fourth quarter operating and financial performance represents a strong end to fiscal year 2014 – an important year for Alliqua BioMedical," said David Johnson, Chief Executive Officer of Alliqua. "The profile of the Company changed dramatically in 2014, with growth in all areas of our organization – from leadership, to sales force and distribution infrastructure, to our portfolio of proprietary advanced wound care products - Alliqua BioMedical made significant progress towards our strategic objective of becoming a market-leading advanced wound care solutions provider."
"We expect continued progress in fiscal year 2015 and look forward to the continued growth in sales of our proprietary products – including our amniotic tissue membrane product Biovance – and the anticipated contributions in the second half of the year from our acquisition of Celleration which we announced earlier this month. We are pleased with our Company's notable progress in just a brief period of time, and we remain focused on continuing to execute our plan which we expect to drive revenue growth and market share gains, improving financial performance and above-average shareholder returns in 2015 and beyond."
Alliqua BioMedical, Inc. and Subsidiaries
Revenue Summary
($, Thousands) Three Months Ended December 31, Fiscal Year Ended December 31
2014 2013 2014 2013
Proprietary Products $1,349.0 $106.2 $3,003.5 $179.0
Contract Manufacturing 315.3 362.6 1,782.6 1,618.7
Revenue, net $1,664.3 $468.8 $4,786.1 $1,797.7
Fourth Quarter 2014 Results:
Total revenue for the fourth quarter of 2014 increased $1.2 million, or 255% year-over-year, to $1.7 million. Sales of the Company's proprietary products – including hydrogels, Sorbion, Biovance and Therabond – increased $1.2 million, or 1,170%, year-over-year. Fourth quarter 2014 revenue includes contributions from Choice Therapeutics, which we acquired in May 2014, of approximately $596 thousand. Excluding the contributions from the acquisition of Choice Therapeutics, the Company's proprietary products revenue increased in the fourth quarter 609%, year-over-year
Gross profit for the fourth quarter of 2014 increased $0.9 million year-over-year to $0.8 million, or 46.7% of sales. The increase in gross margin was driven by the change in product mix due to increased sales of proprietary products which represented 81% of sales in the fourth quarter of fiscal year 2014 compared to 23% of sales during the fourth quarter last year. Gross margin on proprietary product sales was 73% in the fourth quarter of 2014.
Total operating expenses for the fourth quarter of 2014 decreased approximately $7.2 million, or 54% year-over-year, to $6.1 million. Fourth quarter of 2013 total operating expenses included an impairment charge of $8.1 million related to in-process research and development for the Company's Hepamate technology. Excluding the impairment charge, adjusted operating expenses increased $0.9 million, or 18%, year-over-year. The increase in adjusted operating expenses in the fourth quarter of 2014 was driven primarily by higher compensation and benefits related to increased headcount compared to the prior year and the incremental expenses related to our acquisition of Choice Therapeutics. Stock-based compensation was $1.7 million and $2.6 million for the three months ended December 31, 2014 and 2013, respectively.
Loss from operations for the fourth quarter of 2014 was $5.3 million compared to a loss of $13.4 million last year. Net loss for the fourth quarter of 2014 was $5.4 million, compared to a net loss of $14.9 million for the same period last year.
Fiscal Year 2014 Results:
Total revenue for the twelve months ended December 31, 2014 increased $3.0 million, or 166% year-over-year, to $4.8 million. Sales of the Company's proprietary products – including hydrogels, Sorbion, Biovance and Therabond – increased $2.8 million, or 1,577%, year-over-year. Fiscal year 2014 revenue includes contributions from the acquisition of Choice Therapeutics in May 2014 of approximately $1.5 million. Excluding the contributions from the acquisition of Choice Therapeutics, the Company's proprietary products revenue increased 742%, year-over-year.
Gross profit for fiscal year 2014 increased $1.8 million to $1.5 million, or 31.7% of total sales, compared to a gross loss of $249 thousand last year. The increase in gross margin was due to a higher concentration of proprietary product sales. Product sales had a gross margin of 70% in fiscal year 2014. Net loss for the fiscal year of 2014 was $25.4 million compared to a net loss of $22.0 million for the same period last year.
As of December 31, 2014, the Company had $16.8 million in cash and cash equivalents, compared to $12.1 million at December 31, 2013. The increase was largely attributable to net financing proceeds of $14.4 million, proceeds from the exercise of stock options and warrants totaling $6.6 million offset by cash used in operating activities of $13.3 million and $2.0 million used for the purchase of Choice Therapeutics during the twelve months ended December 31, 2014.
Updated Fiscal Year 2015 Revenue Outlook
The Company is updating its revenue guidance for the fiscal year 2015 period. The updated guidance reflects the expected incremental contributions from the acquisition of Celleration, based on a closing date of June 30th.
For the fiscal-year ending December 31, 2015, the Company expects total revenue of $15.5 million to $18 million, representing growth at the mid-point of the range of approximately 250% year-over-year. This compares to the Company's previous expectation for total revenue in fiscal year 2015 in the range of $11 million to $13 million. Celleration revenue for the second-half of fiscal year 2015 is expected in the range of $4.5 million to $5.0 million. We expect sales from our contract manufacturing business to reflect slightly positive growth year-over-year, therefore, the growth rates reflected in the Company's revenue guidance for fiscal year 2015 are primarily generated by expected growth in the sale of the Company's proprietary products.
Conference Call
The Company will host a teleconference at 8:00 a.m. Eastern Time on February 24th to discuss the results of the quarter and fiscal year, and to host a question and answer session. Those interested in participating on the call may dial 888-576-4387 (719-457-2689 for international callers) and provide access code 6093126 approximately 10 minutes prior to the start time. A live webcast of the call will be made available on the investor relations section of the Company's website at http://ir.alliqua.com.
For those unable to participate, a replay of the call will be available for two weeks at 888-203-1112 (719-457-0820 for international callers); access code 6093126. The webcast will be archived on the investor relations section of Alliqua's website.
About Alliqua BioMedical, Inc.
Alliqua is a provider of advanced wound care solutions. Through its sales and distribution network, together with its proprietary products, Alliqua provides a suite of technological solutions to enhance the wound care practitioner's ability to deal with the challenges of healing both chronic and acute wounds.
Alliqua currently markets its line of hydrogel products for wound care under the SilverSeal® and Hydress® brands, as well as the Sorbion sachet S® and Sorbion sana® wound care products, and its TheraBond® 3D advanced dressing which incorporates the TheraBond® 3D Antimicrobial Barrier Systems technology. It also markets the advanced wound care product Biovance®, as part of its licensing agreement with Celgene Cellular Therapeutics.
In addition, Alliqua can provide a custom manufacturing solution to partners in the medical device and cosmetics industry, utilizing its proprietary hydrogel technology. Alliqua's electron beam production process, located at its 16,000 square foot GMP manufacturing facility in Langhorne, PA, allows Alliqua to develop and custom manufacture a wide variety of hydrogels. Alliqua's hydrogels can be customized for various transdermal applications to address market opportunities in the treatment of wounds as well as the delivery of numerous drugs or other agents for pharmaceutical and cosmetic industries.
For additional information, please visit http://www.alliqua.com. To receive future press releases via email, please visit http://ir.stockpr.com/alliqua/email-alerts.
Any statements contained in this press release regarding our ongoing research and development and the results attained by us to-date have not been evaluated by the Food and Drug Administration.
RNWEFY EARNINGS...
Fornebu, February 13, 2015: REC Silicon ASA reported fourth quarter 2014
revenues of USD 126.2 million compared to USD 126.5 million in the third
quarter. Higher polysilicon sales volumes were offset by lower polysilicon
prices and decreased sales volumes of silicon gases.
EBITDA for the fourth quarter was USD 38.0 million. Third quarter EBITDA
included the recognition of USD 101 million associated with the transfer of
technology to the Yulin JV. The underlying comparable EBITDA decreased by
approximately 17 percent compared to the prior quarter, primarily due to lower
polysilicon prices.
The polysilicon and silane gas loading expansion projects at Moses Lake and
Butte are proceeding according to schedule. Building permits have been obtained
and construction activity has commenced. The Yulin Joint Venture is also
progressing according to plan. The contract on detailed engineering has been
awarded and the work has commenced. REC Silicon made the first capital
contribution of USD 75 million to the JV in October 2014.
"Continued focus on efficient and stable operations resulted in record high
production volumes and secured REC Silicon's competitive cost position.
Although challenging market dynamics and the uncertainty created by the US/China
trade dispute led to pressure on solar grade polysilicon prices during the
quarter, REC Silicon's financials remain strong," commented Tore Torvund, CEO of
REC Silicon.
Net financial items resulted in income of USD 112.8 million, mainly reflecting
net currency gains, and fair value adjustment of convertible bonds offset by
interest expense.
Profit from continuing operations was USD 119.0 million in the fourth quarter,
compared to USD 119.5 million in the previous quarter.
Basic and diluted EPS from total operations was USD 0.05 in the fourth quarter
2014, unchanged from the previous quarter.
For more information, please see the attached fourth quarter 2014 report.
Morning program:
The Company will give a presentation at 08:00 a.m. CET today at
Konferansesenteret Høyres Hus, Stortingsgaten 20, 0117 Oslo, Norway. The
presentation will be held in English.
There will be a live webcast from the presentation which can be accessed from:
www.recsilicon.com.
It will also be possible to listen to the presentation through a conference
call. Please make sure to dial in 10 minutes prior to scheduled start time on
one of the following numbers:
Norway: +47 23 50 04 86
UK: +44 (0)20 3427 1909
USA: +1 212 444 0412
International Toll: +44 (0)20 3427 1909
Please provide confirmation code 7022732 and state your name, company and
country of residence.
Afternoon program:
REC Silicon will host an analyst conference call with possibilities for
questions and answers later the same day at 3:00 p.m. CET. Please make sure to
dial in at least five minutes ahead of time to complete your registration.
International dial in: +47 23 50 04 86
Please provide confirmation code 1521035 and state your name, company and
country of residence.
For further information, please contact:
Mitra H. Negård, Investor Relations
REC Silicon ASA
Phone: +47 957 93 631
Email: mitra.negard@recsilicon.com
About REC Silicon
REC Silicon is a leading producer of advanced silicon materials, delivering
high-purity polysilicon and silicon gas to the solar and electronics industries
worldwide. We combine 25 years of experience and proprietary technology with the
needs of our customers, and annual production capacity of more than 20,000 MT of
polysilicon from our two US-based manufacturing plants. Listed on the Oslo Stock
Exchange (ticker: REC), the company is headquartered in Moses Lake, Washington
and employs 720 people.
For more information: www.recsilicon.com
This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)
DGPIF.. $0.615 USD.. Trading crazy in Canada..
DGPIF.. $0.58.. Looking good..
From the Stockhouse Board..
I'm expecting Q4 EPS anywhere between $0.11 and $0.14...so long as there are no other impairments (I don't expect there to be). Look for a good FCF quarter too...
We are going to get at least three consecutive quarters of growth...the stock should perform well this year (it already has).
-------------------------------
Read more at http://www.stockhouse.com/companies/bullboard/t.dgi/data-group-inc#OFcd6dkdk4kFPvtK.99
Read more at http://www.stockhouse.com/companies/bullboard/t.dgi/data-group-inc#OFcd6dkdk4kFPvtK.99
DOGIF.. $0.58.. Been chasing on the bid but every once in a while I just take the offer.. hank
02/06/15 2:35 PM EST Buy 1500 DGPIF Executed @ $0.58 Details | Edit
02/06/15 12:24 PM EST Buy 500 DGPIF Executed @ $0.549 Details | Edit
02/06/15 12:20 PM EST Buy 500 DGPIF Executed @ $0.549 Details | Edit
01/14/15 12:47 PM EST Buy 3000 DGPIF Executed @ $0.5405 Details | Edit
01/07/15 1:24 PM EST Buy 6388 DGPIF Executed @ $0.469 Details | Edit
01/07/15 1:23 PM EST Buy 2500 DGPIF Executed @ $0.4693 Details | Edit
01/07/15 12:06 PM EST Buy 388 DGPIF Executed @ $0.461 Details | Edit
01/07/15 12:05 PM EST Buy 3000 DGPIF Executed @ $0.461 Details | Edit
01/07/15 12:01 PM EST Buy 500 DGPIF Executed @ $0.461 Details | Edit
01/07/15 11:50 AM EST Buy 500 DGPIF Executed @ $0.461 Details | Edit
01/07/15 11:50 AM EST Buy 2000 DGPIF Executed @ $0.461 Details | Edit
01/07/15 11:49 AM EST Buy 2500 DGPIF Executed @ $0.4608 Details | Edit
01/06/15 3:55 PM EST Buy 500 DGPIF Executed @ $0.437 Details | Edit
01/06/15 3:36 PM EST Buy 3500 DGPIF Executed @ $0.437 Details | Edit
01/06/15 3:35 PM EST Buy 2500 DGPIF Executed @ $0.4367 Details | Edit
01/06/15 11:29 AM EST Buy 8500 DGPIF Executed @ $0.438 Details | Edit
01/06/15 11:27 AM EST Buy 2500 DGPIF Executed @ $0.4375 Details | Edit
---------------------------------------------------
DGIPF.. $$0.435.. Up over 10% since the first and I just got tired chasing it.. Looks like a nice position trading stock.. It's real thin and has value by most.. Time will tell but below is the post that got my opinion.. I will have to say their web site doesn't give much in the way of information so I lean on others on this one,, especially the Cdn. BB's .. hank
Nice Company ,, worth the time to DD.. hank
From another posters view..
SSKILLZ1 Member Level Sunday, 01/04/15 12:41:01 PM
Re: None
Post # of 7019
DGI.TO (DGPIF)
I've been buying DGI.TO (sub .40 USD) over the last month for me this is a Table Pounder, and my best idea for 2015. We will see how it does. My DD is below.
Business Services
This is the stock I have been buying the whole month of December, and even brought a little on Friday. It is 6% of my personal portfolio which for me is a huge position as this is my top pick of 2015. Here is what I like.
Turnaround Play- DGI.TO is a turnaround play that is based on threefold approach, revenue stabilization and then growth, cutting costs and making themselves far more efficient and profitable, and reducing debt. The Next question is how are they doing?
Revenues: have stabilized in fact last quarter was the first quarter where they showed revenue growth in a while, I expect the stabilization/Growth to continue in my opinion. They have won a lot of new business to increase revs which is very positive in my opinion.
Cutting Costs: They have taken a ton of overhead out of the business. In fact they are consolidating 4 facilities, to 1 state of the art facility in q1 of 2015, that is expect to save 2.5-3 Million annually, we are talking about adding about .08 -.10 after tax eps to the bottom line next year on this alone.
Reducing Debt: Since 2013 they have reduced long-term debt by approximately 10 Million and Paid down the bank loan by 2 million just this quarter alone. I expect debt to continue to be reduced and handled by the enormous bottom line profits we are seeing.
Q3 and 9 Months Ended
The company reported 5.4% y/y revenue growth, and .08 eps. And for Nine Months ended we have seen .12 EPS. If we ex out restructuring costs (which I believe we should) we are looking at .09 and .19 for 3 and 9 months respectively.
Q4 and the Look Ahead
In the q3 CC, when asked about q4. They said they were optimistic it would be the best quarter of the year. I expect .10-.15 in q4 (Ignoring restructuring expenses).
As for next year I expect revs to be in line to slightly up next year, so I expect .40-.50 (Ignoring restructuring expenses)
Valuation
If my 2015 estimates are correct the stock will be trading at a PE of roughly 1. Now I realize there are concerns and I will address them in a bit But I don’t see why this stock can’t get a 3-5 PE rather easily, will increase the current share price by 200-400% if my numbers are proven to be correct, in my opinion there is no stock with higher upside potential then DGI.TO at this point in the market right now.
The Concerns
Balance sheet is admittingly weak, but there earnings should be easily enough to support and continue to reduce their debt levels in my opinion.
The second concern is should we ex out the never ending restructuring expenses. I believe we should, and I believe these restructuring expenses should be exed out because they are actually showing that there is a result, these expense have clearly led to reducing unnecessary overhead on both the square footage and personal side reflected into lower operating expenses. Also it is important to note restructuring expenses have been dropping y/y, I expect that to continue as more of the cost savings plan is realized and is behind them. q1 will should see a rise because a specific event that is gonna be long term helpful on both the cost side, and the efficiency side of the business.
Why the stock price is at lower levels? Well I believe Tax loss selling was a huge reason, as I said many times when a company is at its lows at and has a good November quarter it has 0 Value to the stock price during that year. Having said that it is now 2015, that is behind us now and as this exciting turnaround/absurdly cheap Valuation story comes to light I expect people will get excited, because there is a lot to get excited about here, as it might be the cheapest stock I have ever seen.
Why am I Table Pounding on DGI.TO (DGPIF)? I think DGI.TO is one of the cheapest stocks I have ever seen, I admit there are some warts, but the stock is priced for unmitigated disaster anything better should cause the stock to double, triple or even more in 2015.
Conclusion: I think DGI.TO (DGPIF) is absurdly undervalued, and now that we are finally starting to see some revenue growth, along with additional cost saving that will be very helpful to increasing the bottom line in 2015. All is just my opinion, and I could always be wrong though.
AMPG.. $0.0175.. I added at $0.0174 and $0.0175.. BMAK only sold 15,000 at first but came back and sold another 38888.. It's almost like he now needs permission to sell more.. After sale he went up to $0.0185.. I think the supply is running out.. Bought a total of 88,888.. hank
AMPG $0.0175 AmpliTech Group Reduces Debt and Lowers Operating Expenses
BOHEMIA, N.Y., Feb 03, 2015 (GLOBE NEWSWIRE via COMTEX) -- AmpliTech Group, Inc. (OTCQB:AMPG) announced it has successfully lowered its public company operating expenses by 86% compared to last year (ending 12/31/2014) in an effort to improve its balance sheet and profitability for 2015. Many of these expenses were non-recurring and non-cash expenses. CEO Fawad Maqbool stated, "We have made significant changes in order to support our shareholders and investors by accomplishing major goals in the past few months." Below are some key highlights:
-- Reduction of public company expenses by 86% (convertible debt interest, legal fees, etc.)
-- Satisfied our floorless convertible (toxic) debt.
-- Eliminated long term debt (loans)
-- No short term debt
-- Minimal liabilities and payables
-- Reduction of outstanding shares
-- Increased revenue in last quarter of 2014
Mr. Maqbool added, "Our goal is to restructure our management and financial status to improve the company's overall performance and growth. This past year we have paid off debt and overcome the many obstacles micro-cap companies face in their infancy. We are grateful for our shareholders' support through this critical period. AMPG is poised for a breakout year in 2015 with planned acquisitions, equity investment, and disruptive technology development."
For additional investor information please contact James Moldenhauer, CEO of JP Fortune Group at 714-420-2004.
About AmpliTech Group, Inc.
AmpliTech Group, Inc. designs, develops, and manufactures custom and standard state-of-the-art RF components for the Domestic and International, SATCOM, Space, and Military markets. These designs cover the frequency range from 50 kHz to 40 GHz - eventually, offering designs up to 100 GHz. AmpliTech also provides consulting services to help with any microwave components or systems design problems. Our steady growth over the past 13+ years has come about because we can provide complex, custom solutions for nearly ANY custom requirements that are presented us. In addition, we have the best assemblers, wires, and technicians in the industry and can provide contract assembly of customers' own designs. Click here to view AmpliTech video. Website: http://www.AmpliTechinc.com
Forward-looking Statements
This release contains statements that constitute forward-looking statements. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company's financing plans; (ii) trends affecting the Company's financial condition or results of operations; (iii) the Company's growth strategy and operating strategy. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.
CONTACT: Fawad Maqbool, CEO, AmpliTech Group, Inc. (631) 521-7831
James Moldenhauer, CEO, JP Fortune Group (714) 420-2004
http://www.globenewswire.com/newsroom/ti?nf=MTMjMTAxMTgyOTgjMjg5NTE=
(C) Copyright 2015 GlobeNewswire, Inc. All rights reserved.
http://www.otcmarkets.com/stock/AMPG/news
KLYG. Nice call on this one. I tried to buy some a while back but the bid was $0.07 and the ask was $0.10 and after my order didn't fill over a couple days I just gave up.
FVRG. I was told by IR they think the current net margins are now 5%. If so they should start some bigger Q's soon. If they would even hit a $0.03 Q I think the stock would get a big rally from that.
FVRG.. $0.77.. ForeverGreen Worldwide Corporation Issues Guidance
Company anticipates 2015 full year revenue of $90-100 million, 55-70% growth over 2014
Net income of $3.6-5 million expected
PLEASANT GROVE, Utah, Dec. 10, 2014 /PRNewswire/ -- ForeverGreen Worldwide Corporation (OTCBB: FVRG), a leading direct marketing company and provider of health-centered products, today announced 2015 guidance.
"During 2014, we saw a significant jump in revenue and acceptance of our products worldwide. We needed to raise our guidance several times, and we hit nearly all our corporate goals. Next year, we expect our sales growth trends to continue. Our revenue should be in excess of $90 million. We are continuing to see a positive impact on our business from our investment in IT, logistics, inventory and management. We expect operating and net margins to increase as we benefit from economies of scale, pricing leverage and sales growing faster than fixed expenses. For the full year, we anticipate net margins of 4-6%," said Jack Eldridge, CFO.
Mr. Eldridge continued, "During the current year, we concentrated on driving growth and educating the marketplace about our exciting product line. For 2015, we look to find a balance between further acceleration of sales and maximizing cash flow and profitability. We will continue to keep shareholders updated on our goals and targets for 2015."
ForeverGreen Worldwide Corporation develops, manufactures and distributes an expansive line of all natural whole foods and products to North America, Australia, Europe, Asia and South America, including their new global offerings, PowerStrips, SolarStrips and BeautyStrips. They also offer Azul and FrequenSea(TM), whole-food beverages with industry exclusive marine phytoplankton, the Versativa line of hemp-based whole-food products, immune support and weight management products, Pulse-8 powdered L-arginine formula, TRUessence(TM) Essential Oils and Apothecary, 24Karat Chocolate(R) and an entire catalog of meals, snacks, household cleaners and personal care products.
http://www.fgxpress.com
FVRG.. $0.77.. ForeverGreen Worldwide Corporation Ends Year with Triple-Digit Year-Over-Year Growth
Jan 16, 2015 08:15:00 (ET)
ForeverGreen's December 2014 sales increase 150%
PLEASANT GROVE, Utah, Jan. 16, 2015 /PRNewswire/ -- ForeverGreen Worldwide Corporation (OTCBB: FVRG), a leading direct marketing company and provider of health-centered products, announced today that December 2014 revenue exceeded December 2013 sales by more than 150%.
"During December 2014, our sales were approximately $5.8 million compared to $2.25 million during December 2013. For the year, we achieved our forecasted targeted revenue of over $56 million. In 2014, we increased our revenue each quarter as we have for the last eight quarters. We established strong sales growth, strong leadership, strong vendor relationships and strong corporate infrastructure during 2014. As a result of ForeverGreen's continued development of new products, expansion into various countries and onboarding of members and leaders, we anticipate 2015 to be another successful year, with revenues escalating to $90-100 million," said Jack Eldridge, CFO.
FVRG.. $0.77.. ForeverGreen Worldwide Announces Q2 2014 Results
2014 Q2 Revenues Grow 253%
Gross Profit Increases 294%
Company Achieves Record Sales and Net Income
OREM, Utah--(BUSINESS WIRE)-- ForeverGreen Worldwide Corporation (OTCBB:FVRG), a leading provider of nutritional foods and other healthy products, today announced Q2 2014 earnings. The quarter ended June 30, 2014.
Recent Company Highlights:
New leaders, distributors and customers added at record pace each month during 2014
Company achieved fifth consecutive quarter of operating profitability and second consecutive quarter of growth in operating and net income
Sales increased each quarter for the last 5 quarters
Company actively shipped product in 174 countries, up from just 150 at end of 2013
Company added new product, SolarStrips, to product portfolio
Company expanded to new corporate headquarters in Pleasant Grove, UT
Company met or exceeded monthly targets necessary to remain on target for the increased company guidance of $41-50 million of revenue during 2014
Highlights for Q2 2014 included:
Sales increased to $14,127,840 from $4,007,611 for Q2 2013, a 253% increase
Gross profit rose to $11,233,332 compared to $2,852,371 during Q2 2013, a 294% increase
Gross profit margins increased to 79.5% versus 71.1% during the comparable quarter during 2013
Operating income was $412,360 compared to $92,653, a 345% increase
Net income totaled $454,856 or $0.02 EPS versus a net loss of $5,383
Operating expenses excluding sales and marketing declined as a percentage of revenue from 31.9% in 2013 to 24% in 2014
Interest expense decreased to $70,407 or 0.05% of sales compared to $92,995 or 2.3% of sales during Q2 2013
ForeverGreen Revenue/Income Progression
Revenue % Growth Operating Income Net Income
($ Millions) (Q vs. Q) ($ Thousands) ($ Thousands)
1Q 2013
2.7 (96) (211)
2Q 2013
4.0 48.7% 93 (5)
3Q 2013
4.8 19.6% 302 327
4Q 2013
6.3 30.6% 84 7
1Q 2014
10.5 68.3% 267 181
2Q 2014
14.1 34.3% 412 455
Highlights for six months, ending June 30, 2014, included:
Sales increased to $24,664,242 versus $6,702,089, a 268% increase
Gross profit rose to $19,210,729 from $4,707,519, a 308% increase
Gross profit margins increased to 77.9% compared to 70.2% for 1H 2013
Operating income increased to $679,361 versus a net loss of $3,039
Net income totaled $635,907 or $0.03 EPS as compared to a net loss of $216,839 during 1H 2013
Interest expense decreased to $145,258 compared to $209,374 during the first six months of 2013
Total assets increased to $5,375,883 from $2,699,519 on December 31, 2013
Total liabilities increased nominally to $6,357,005 from $6,301,037 on December 31, 2013
“Total operating expenses for the quarter, excluding sales and marketing, declined from 31.9% in 2013 to 24.0% in 2014,” said Allen Davis, COO. “Primarily, this was due to an increased awareness of expense management. Cost of goods sold increased to $2.9 million or 20.5% of sales compared to $1.2 million or 28.9% of sales. This was largely a result of optimizing pricing with our key vendors and change in product mix.”
CFO Jack Eldridge added, “We experienced a 253% increase in sales over the corresponding quarter in 2013, solidly within the previously announced guidance of $13-15 million we issued for the quarter. Gross margins, operating margins and net profit margins all continue to improve. We expect our net operating margins and our net profit margins to continue to increase with logistical improvements and economies of scale. We believe during the next 12-18 months our operating margins will improve to 12-15% and our net margins will increase to 7-9% as we continue to benefit from overall efficiencies and lower COGS. Several non-recurring costs will be reduced as we move into the second half of the year. We anticipate solid cash flow each quarter. ForeverGreen currently has enough tangible assets to cover its current liabilities and has improved its financial health substantially over the last year. We have achieved several of our 2014 goals already, including the introduction of a new product, SolarStrips. We remain on track to meet or exceed our previously announced revenue guidance of $41-50 million, anticipating net margins of 4-7%. We will continue to develop ForeverGreen into one of the largest and most diversified global companies in our industry. We look forward to discussing our progress on the conference call Tuesday.”
For a full earnings report, please view our entire filing at www.sec.gov.
SYEV.. $0.135... Looks like the latest stock action got SYEV to put some money aside.. SYEV has a cash wad that I would like to see go for other purposes but the spend $150,000 on a stock repurchase don't seem like a bad idea to put a floor under last Qtrs. earnings.. All Ave down around the $0.14 level if it happens.. SYEV has cash and def. tax assets of $0.0945 per share on the books.. At this level SYEV is selling for only 38% above cash and Equil.. hank
Seychelle Initiates a 1,000,000 Share Buy-Back Program ,,,,,,
Business Wire - Jan 20 09:07 EDT
Alert hits:/sy
Company Symbols: OTC-PINK:SYEV
SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)-- Seychelle Water Filtration Products, a DBA of Seychelle Environmental Technologies, Inc. (OTC Bulletin Board: SYEV), a worldwide leader in the development, assembly and sale of proprietary portable water filtration bottles made the following announcement today.
We believe that our common shares are currently undervalued. As a result, our Board of Directors has adopted effective January 19, 2015, a common share buy-back program to reduce the number of outstanding shares authorizing our management to enter the market to re-purchase up to 1,000,000 of our common shares at such times and market price or prices as management may deem appropriate. This common share buy-back program will be reviewed by our Board on at least a quarterly basis.
The Stock Broker representing Seychelle in this stock buy-back transaction is Mr. Joey Rocca with Wilson Davis at 801-415-1313.
With Seychelle portable water filtration, consumers can drink, with complete confidence, perfectly filtered water that is great-tasting from a variety of sources – the tap, rivers, streams, ponds or creeks. The regular filter works for water from the tap while the standard and advanced filters are needed for most outdoor uses. The proprietary Seychelle Ionic Adsorption Micron Filtration has been tested extensively by Independent Government Laboratories in the US and throughout the world to strict EPA/ANSI protocols and NSF Standards 42 and 53 by Broward Testing Laboratories.
“Perfectly Filtered Water For a Great Taste and a Healthier Life”
Note to Investors
This press release may contain certain forward-looking information about the Seychelle’s business prospects/projections. These are based upon good-faith current expectations of Seychelle’s management. Seychelle makes no representation or warranty as to the attainability of such assumptions/projections. Investors are expected to conduct their own investigation with regard to Seychelle. Seychelle assumes no obligation to update the information in this press release. For more information, please visit www.seychelle.com or call (949) 234-1999.
Seychelle Environmental Technologies, Inc.
Dick Parsons, 949-234-1999
dickparsons@seychelle.com
Source: Seychelle Environmental Technologies, Inc.
KLYG.. $0.105.. Can't find any news but I'll take it for what it's worth.. Wish it had come back to the $0.07's again but it looks as though those day's are gone.. The New PR guy seems to be worth what they are paying him if this is his work.. hank
KLYG..$0.09.. Table Pounder.. It looks like we are on our way to becoming either a great stock or takeover.. hank
Custom Cranial Implant Company Aims For Big Push In 2015
Posted in Implantable Devices by Arundhati Parmar on December 11, 2014
A Connecticut company wants to take more market share in the custom cranial and facial implant world.
Kelyniam CEO Tennyson Anthony holds up a model skull with the company's cranial implant
The established names in the world of custom cranial and facial implants are the likes of Biomet, Stryker and Synthes.
However, there are small, boutique firms as well that compete with the big guys for the surgeon's mindshare. One such small manufacturer with roots in aerospace mechanical engineering and rapid prototyping wants to make a big play in 2015 by taking a large chunk of the revenue pie.
Kelyniam, based in Canton, Connecticut, believes it can do that because of a combination of rapid turnaround times and ease of implant placement. The company has been selling its custom implants made of polyether ether ketone (PEEK) OPTIMA, a colorless organic thermoplastic polymer that is transparent to X-rays, since January, 2012 after obtaining approval from the FDA in April, 2011.
That gap was meant to ensure that Kelyniam could create a scalable product development and manufacturing process, says Tennyson Anthony, president and CEO of the company in a recent phone interview.
“We are very confident that we can handle a significant volume without a hitch” or increase in turnaround times, Anthony declares.
Since 2012, roughly 400 procedures have involved Kelyniam’s implants. The company has market clearances in the U.S. and the Middle East, and the company is working to obtain regulatory clearances in Canada and Australia.
The goal is to have significant growth in 2015 and gain a foothold in the facial implant market as well, where most implants are typically off-the-shelf products.
So what is Kelyniam’s turnaround time?
From the time that the company receives a CT scan to when the implant is available for surgery can take as little as 24 hours.
Kelyniam executives underscore that the rapid turnaround time is a competitive advantage. Other implant makers take several days if not weeks to produce their implants.
“I think one of the most interesting things that I have learned in the short time that I have been here, is this less than 24-hour turnaround,” says John Mulvihill, vice president of sales, who joined Kelyniam in November as part of an acquisition. “That is unheard of not only in this market but in many others almost to the point that we have a number of our competition that calls us and orders the Kelyniam custom implant for their cases because their system hasn’t shown up yet.”
A plastic surgeon says it’s not that common for facial implants to be custom made. Usually off-the-shelf products work, but when they need to be custom made that takes some time.
“These custom implants generally require several weeks before being available. The facial plastic surgeon works with the company to create an appropriate implant,” says Houtan Chaboki, plastic surgeon, George Washington Medical Faculty Associates in Washington, D.C, in an email.
But cranial implants, sometimes can be made "on the spot" by head or neck surgeons, neurosurgeons or plastic surgeons using a“combination of titanium plates and/or hydroxyapetite or similar material,” he explains.
Kelyniam’s website offers three plans for custom cranial implants – an expedited plan whose turnaround time is 24 hours, a second plan by which the product is ready for the surgeon in 72 hours while a third plan makes the implant available in five or six days.
Another company – Kelyniam competitor Dallas-based MedCAD - that also makes implants using PEEK polymer can produce them in a few days.
“Is it humanly possible to create an implant within 24 hours? Yes, but it’s not necessary,” says Nancy Hairston, CEO of MedCAD.
She says that her company’s products are rarely used in emergency trauma scenarios because typically you have to wait for the swelling to go down.
“To be honest, if they need it in 24 hours that means somebody hasn’t been organized and they are rushing to bring the patient in,” Hairston declares.
For Kelyniam, the market is split 50-50 into trauma cases and implants required as a result of diseases such as tumor resections, Anthony explains.
“One of the things that we feel sets us apart from our competition is that we are having great success in working with the surgeons and designing an implant even before the resection so that it can be done in one surgery, where the surgeon goes in and takes the tumor out and then have the implant right there to put in,” he says.
One of the company’s products is an implant with tabs already in place.
“It’s an actual extension of the PEEK implant and surgeons don’t need to get a separate plate during surgery, so they can just place the implant on and use the screws that are available there,” explains Mulvihill. “So this really saves a lot of time and money.”
And that becomes important at a time when hospitals are making purchasing decisions with a laser-like focus on cost containment.
“We are very conscious of where the healthcare field is going and everybody is looking for better value,” Anthony says. “So we come in with these tabs and we eliminate the need for plating that can save them upwards of $2,000 for a particular procedure just in plates and screws.”
Kelyniam's outside spokesman noted that the 24-hour turnaround time also helps to free up hospital resources because it means patients are spending less time in the hospital waiting for the implant depending on the type of case.
custom cranial implant, skull implant, trauma
Digital Image of Four-Piece Implant
Recently, the company helped create an implant for a U.S. patient that was particularly challenging. The patient had a gunshot wound, and from the CT scans, it was fairly obvious that there had been a previous surgery to secure broken bone, says Merwin Schaefer, Kelyniam’s chief design engineer.
“The part was created to mimic normal functioning of a healthy bone while reducing surgery and patient recovery times,” Schaefer says.
In fact, the final implant was a puzzle of four different pieces.
“The pieces were all slipped through a small incision and assembled once inside, which greatly reduced scarring and swelling and provided for a much better structural and aesthetic outcome,” Schaefer says.
Schaefer and company executives declined to say where the surgery was done because they are not at liberty to disclose details.
Already some physicians are noticing the Kelyniam difference, Tennyson says.
“We have had a doctor tell us that he truly believes that we saved a couple of his patients' lives because they came in and they were diagnosed with a tumor and they needed radiation treatment right away and because we were able to turn around the implant [quickly] that patient could receive the treatment within 48 hours,” he says.
Executives are hoping that such experiences will have a big impact on the company’s financial fortunes in 2015. The hope is also that a recent acquisition which brings the ability to bring to market neurostimulation products will boost financial results.
In the third quarter, Kelyniam had sales of $455,401 with a loss of $72,302. Kelyniam went public in 2008 and its stock is available over the counter.
Meanwhile, as it competes with companies like MedCAD, Kelyniam will also have to contend with the likes of Oxford Performance Materials, which has won FDA approval for its 3-D printed cranial and facial implants.
-- By Arundhati Parmar, Senior Editor, MD+DI
arundhati.parmar@ubm.com
===========================================================
KLYG.. $0.073 I spoke to the New PR guy who was actually aboard when KLYG traded above a Buck and he said that the tech and expertise was the reason for them buying another company.. I don't remember the 8K saying anything about sales.. I've followed KLYG for over 4 years now and they have rarely done anything to surprise me.. It is a small company and sales can vary a great deal on a few difference in the number of products being sold..
If you search Hank's Trading over the years you will find much Info not else where kept.. I believe that thier Implant's are finally gaining a grip on the market and that is thier reason to hire a PR firm.. Give him a call and he will cheer you up on any bad day in the market.. BTW I able to add 90,000 @0.07 Just before Xmas.. I think after the end of first Qtr. we could see $0.15 or higher.. Stockholders equity increased another 8% during the past qtr..
KLYG..$0.073
Statement of Income
For the 2nd and 3rd Quarter Ended September 30, 2014
KELYNIAM GLOBAL, INC.
June 30, 2014,, September 30, 2014,, Year to Date
Sales $436,865 $455,401 $1,432,552
Cost of Sales 222,138 172,674 665,310
Gross Profit 214,727 282,727 767,242
General and administrative expenses 221,070 210,427 649,445
Income from Operations (6,343) 72,300 117,797
Other Income
Interest income 2 2 8
Net Income (6,341) 72,302 117,805
www.kelyniam.com
STOCKHOLDERS’ EQUITY
Common stock, $.001 par value, 60,000,000 shares authorized,
19,526,800 shares issued, 19,526,800 outstanding 19,017 19,017
Additional paid-in capital 2,436,564 2,436,564
Retained earnings (Deficit) (1,697,763) (1,654,001)
Total stockholders’ equity 757,818 801,580
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $1,444,223 $1,452,852
KELYNIAM GLOBAL, INC.
Internally produced by Kelyniam - these financials have not been reviewed, audited, or compiled.
BALANCE SHEET
June 30, 2014
September 30, 2014
ASSETS
CURRENT ASSETS
Cash $63,599 $75,138
Accounts receivable 212,235 286,855
Inventory 54,576 16,632
Prepaid rent 3,752
Investment securities available for sale 160,777 131,455
Total current assets $491,187 $513,832
CAPITAL ASSETS
Manufacturing Equipment 359,582 359,582
Computer Equipment 24,982 24,982
Furniture and Fixtures 8,043 8,043
Leasehold Improvments 189,455 189,455
582,062 582,062
Less accumulated depreciation (322,483) (335,735)
Total capital assests 259,579 246,327
OTHER ASSETS
License, net of accumulated amortization of $9,930 35,139
License, net of accumulated amortization of $11,458 34,375
Security Deposit 8,000 8,000
Deferred income tax asset 650,318 650,318
Total other assets 693,457 692,693
TOTAL ASSETS $1,444,223 $1,452,852
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Notes payable $78,125 $63,750
Line of Credit - Bank 165,623 165,623
Credit cards payable 987
Commissions payable 47,245 35,150
Accrued expenses 64,293 74,630
Accrued interest 9,803 6,291
Current portion of capital leases 9,282 30,674
Current portion of long-term debt 30,238 26,880
Total current liabilities $405,596 $402,998
LONG-TERM DEBT
Long-term debt, less current portion 229,464 222,809
Capital lease obligations, less current portion 51,345 25,465
Total long-term debt 280,809 248,274
STOCKHOLDERS’ EQUITY
Common stock, $.001 par value, 60,000,000 shares authorized,
19,526,800 shares issued, 19,526,800 outstanding 19,017 19,017
Additional paid-in capital 2,436,564 2,436,564
Retained earnings (Deficit) (1,697,763) (1,654,001)
Total stockholders’ equity 757,818 801,580
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $1,444,223 $1,452,852
OIL.. This is either the bottom or an article that need consideration.. hank
(Reuters) - U.S. bank Goldman Sachs slashed it oil forecasts on Monday, saying fuel prices needed to stay low for much longer in order to curb production and end a global supply glut.
Goldman Sachs oil analysts led by Jeffrey Currie said the collapse in oil prices over the last six months, which has brought North Sea Brent crude down almost 60 percent to below $50 a barrel, would eventually balance the market.
But they said crude oil prices could come down much further in the short term, possibly into the high $30s a barrel before the market saw a rebound.
Goldman Sachs is one of the most influential U.S. banks in commodities markets. In 2008, when oil prices were racing up toward their all-time high at almost $150 a barrel, the bank forecast crude could hit $200.
The bank said on Monday it had cut its 2015 forecast for Brent to $50.40 a barrel from $83.75 and reduced its 2015 WTI price forecast to $47.15 per barrel from $73.75.
For 2016, Goldman Sachs sees Brent at $70 and WTI at $65, down from $90 and $80 respectively.
In the short term, Goldman Sachs was even more bearish:
"To accommodate the substantial expected first half inventory build and using the storage arbitrage to the one-year ahead swap, we are revising down our 3-, 6- and 12-month price forecasts for Brent to $42, $43 and $70 respectively, from $80, $85 and $90," the bank said in a report to clients.
WTI 3-, 6- and 12-month price forecasts have been cut to $41, $39 and $65 from $70, $75 and $80 a barrel.
"While history would suggest that a storage blow-out would push spot prices below $35, we believe that by avoiding breaching storage capacity, the market will hover around $40, potentially dipping at times into the high $30s which we see as the likely lows of this cycle," the report said.
MAUXF..$0.51.. Sold a few more above $0.50 and the bids seem to have been stronger as the price advances.. Looks like $0.52 could/should be the top .. Only 19K to go.. That was quick I'm out and await the next sell off.. hank
NHLD.. $0.47.. Have been buying during the past few day's and heres why.. Insider buying has also occurred.. A 1 for 10 reverse is coming and that should help the price movement.. just a cheap stock period.. hank
National Holdings Corporation Reports Record Financial Results in Fiscal Year 2014
Achieves Full Year Revenue Increase of 44%, Operating Income Increase of 338% and Net Income of $18.6 Million or $0.15 per share
Plans to Complete 1:10 Reverse Stock Split and Apply for National Stock Exchange Listing in January 2015
Management to Host Conference Call on January 12, 2015 at 5:00 p.m. ET
National Holdings Corporation (OTCBB:NHLD) (”National Holdings” or the “Company”), a full-service investment banking and asset management firm, today announced financial results for the Company’s fiscal year ended September 30, 2014.
Fiscal 2014 Highlights
• Increased revenues by $56.7 million, or 44%, to $184.3 million, compared with revenues of $127.6 million for the same period last year
• Achieved organic growth on core business units of $20.1 million or 15.7%
• Completed the previously announced merger integration of Gilman Ciocia, adding $36.6 million of revenue and expanding the Company’s core retail brokerage and asset management operations, while adding a new diversification to the business mix with the tax preparation and accounting service
• Generated net income of $18.6 million, or $0.15 per basic and diluted share for the year ended September 30, 2014, compared with net income of $1.6 million, or $0.02 per basic and diluted share for the same period last year
• Recorded in the fiscal fourth quarter, a deferred tax benefit, which resulted in an income tax benefit of $10.8 million for the fiscal year ended September 30, 2014
• Increased Adjusted EBITDA, a non-GAAP measure, by 159% to $10.4 million, compared with $4.0 million for the same period last year
• Reported total stockholders’ equity of $44.5 million, which represents an increase of 182% from September 30, 2013.
Robert Fagenson, National Holdings’ Executive Chairman and Chief Executive Officer, commented, “The Company delivered record financial results in fiscal year 2014, highlighted by increases in all key metrics, including revenue, operating income, adjusted EBITDA and net income. Operationally, we saw continued strong contributions from all major business segments, including retail brokerage, investment banking and asset management. Following the successful merger integration of Gilman Ciocia, we now offer our clients an enhanced platform, which includes tax preparation and accounting services. Our record net income and adjusted EBITDA results are a tribute to the consistent focus of our management team and operating staff on managing expenses and margin improvement. With approximately $24.5 million in cash and no debt, we remain well positioned to continue executing our growth strategy.”
Mr. Fagenson continued, “We plan to inform FINRA this week of our plans to execute a 1:10 reverse split of the Company's issued and outstanding common stock, which was authorized by stockholders following National Holding’s most recent annual meeting. Once implemented, the reverse stock split is intended to facilitate the listing of National Holding's common stock on a national stock exchange.”
Mark Goldwasser, National Holdings’ President and Chief Executive Officer of the Company’s broker-dealer subsidiary, National Securities, added, “In fiscal 2014, our record financial results were largely driven by the continued strong performance of our core retail brokerage operations and investment banking, which were supplemented by the brokerage and investment advisory businesses we acquired in the Gilman merger. For the 12 months ended September 30, 2014, commissions increased 46% to $114.3 million and investment banking revenues increased 36% to $19.0 million when compared with our fiscal year 2013 results. Our investment banking group served as lead or co-lead manager in 58 transactions to emerging growth companies in our target markets. To further support our institutional and retail clients we’ve also expanded our equity research team to cover the technology, oil & gas, REIT and BDC sectors. Our asset management unit contributed to the top line growth with revenues increasing 49% to $14.2 million, which also benefitted from the successful integration of Gilman’s asset management and financial planning business.”
Year Ended September 30, 2014 Financial Review
National Holdings reported fiscal 2014 revenue of $184.3 million, an increase of $56.7 million, or 44%, over revenue of $127.6 million reported in fiscal 2013. This increase included $20.1 million of organic growth as well as $36.6 million of revenues directly attributable to the merger with Gilman Ciocia, which further expanded the Company’s team of registered representatives, investment advisors and insurance sales representatives, as well as further diversifying the Company’s business to include tax preparation and accounting services.
Total expenses increased 40% or $50.7 million, to $176.5 for the year ended September 30, 2014, compared with $125.8 million in the year ended September 30, 2013. The increase in total expenses is consistent with the factors outlined above.
Adjusted EBITDA, a non-GAAP measure, increased $6.4 million, or 159%, to $10.4 million in the year ended September 30, 2014, compared with $4.0 million in the year ended September 30, 2013.
Income from operations for the year ended September 30, 2014 increased to $7.8 million, compared with $1.8 million for 2013, representing an increase of $6 million or 333%. On a GAAP basis, net income for the year ended September 30, 2014 increased to $18.6 million, or $0.15 per basic and diluted share, compared with net income of $1.6 million, or $0.02 per basic and diluted share in 2013. Of note, the Company recorded an income tax benefit of $10.8 million in the fourth quarter of fiscal 2014, after utilization of the Company’s net operating loss carryforward to offset taxable income for 2014 and the corresponding reversal of a portion of the valuation allowance, the Company’s remaining valuation allowance of approximately $11.9 million, including $1.8 million recorded in connection with the acquisition of Gilman, was reversed and recorded as a deferred tax benefit in the consolidated statement of operations.
Balance Sheet
As of September 30, 2014, National Holdings had $24.5 million in cash and no long term debt. The Company reported total stockholders’ equity of $44.5 million, which represents an increase of 182% from September 30, 2013.
Business Update
1:10 Reverse Split of Common Stock
Since the end of the fiscal fourth quarter 2014 and pursuant to the authorization previously granted by stockholders at the Company’s most recent Annual Meeting of Stockholders, the Board of Directors intends to effect a 1-for-10 reverse stock split of the Company's issued and outstanding common stock. The reverse stock split is intended to facilitate the listing of National Holding's common stock on a national stock exchange.
National Securities Expands Equity Research Team with Appointment of Three Research Analysts
In December 2014, the Company’s broker-dealer subsidiary, National Securities Corporation, expanded its team of equity research analysts with the appointments of Ilya Grozovsky, Glenn Williams and Chris Testa. Mr. Grozovsky will serve as a Senior Equity Analyst covering the Technology sector, including software, cloud computing infrastructure and applications. Mr. Williams will cover the Oil & Gas sector. Mr. Testa will serve as an Equity Research Analyst, covering Business Development Companies (BDCs). In their new roles, Mr. Grozovsky, Mr. Williams and Mr. Testa are based in New York.
Conference Call
National Holdings will host a conference call to discuss its fiscal 2014 financial results and provide a business update on Monday, January 12, 2015, at 5:00 p.m. ET. To access the teleconference, please dial (706) 902-2067 (domestic and international) approximately ten minutes before the teleconference’s scheduled start time and reference ID # 60993430.
If you are unable to access the live teleconference, a replay will be available beginning approximately two hours after the call’s completion and available through January 19, 2015. The teleconference replay can be accessed by dialing (404) 537-3406 (domestic and international) and entering the ID# 60993430. An audio file replay will also be available on the investor relations portion of National Holding’s website at http://www.nhldcorp.com/investors.aspx.
About National Holdings Corporation
National Holdings Corporation is a full-service investment banking and asset management firm that provides a range of services, including independent retail brokerage and advisory services, investment banking, institutional sales and trading and equity research, financial planning, market making, tax preparation, insurance and annuities, to corporations, institutional investors and high net-worth clients. With over 1,100 independent advisors, brokers, traders and sales associates, the Company is a leading Independent Advisor and Broker services company. National Holdings operates through five subsidiaries: National Securities Corporation, vFinance Investments, Inc., National Insurance Corporation, National Asset Management, Inc. and Gilman Ciocia, Inc. The Company was founded in 1947 and is headquartered in New York and Florida. For more information, visit www.nhldcorp.com.
Safe Harbor Statements
This release contains forward-looking statements within the meaning of the federal securities laws. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Information on significant potential risks and uncertainties that may also cause differences include, but is not limited to, those mentioned by National Holdings from time to time in their filings with the SEC. The words “may,” “will,” “believe,” “estimate,” “expect,” “plan,” “intend,” “project,” “anticipate,” “could,” “would,” “should,” “seek,” “continue,” “pursue” and similar expressions and variations thereof identify certain of such forward-looking statements, which speak only as of the dates on which they were made. National Holdings undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may be disclosed from time to time in our SEC filings or otherwise, including the factors discussed in Item 1A, Risk Factors, of our Annual Report on Form 10-K and in or periodic reports on Form 10-Q, and, therefore, readers should not place undue reliance on these forward-looking statements.
(Financial Tables Follow)
NATIONAL HOLDINGS CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION
September 30,
2014 2013
ASSETS
Cash $ 24,465,000 $ 19,985,000
Restricted Cash 92,000 92,000
Cash deposits with clearing organizations 1,005,000 1,107,000
Securities owned at fair value 1,061,000 467,000
Receivables from broker dealers and clearing organizations 4,985,000 4,296,000
Forgivable loans receivable 662,000 436,000
Other receivables, net 3,998,000 1,424,000
Prepaid expenses 932,000 764,000
Fixed assets, net 752,000 447,000
Intangible assets, net 7,595,000 -
Goodwill 6,531,000 -
Deferred tax asset, net 11,925,000 -
Other assets, principally refundable deposits 790,000 493,000
Total Assets $ 64,793,000 $ 29,511,000
LIABILITIES AND STOCKHOLDERS’ EQUITY
Liabilities
Accrued commissions and payroll payable $ 13,520,000 $ 9,332,000
Accounts payable and other accrued expenses 5,636,000 4,108,000
Securities sold, not yet purchased at fair value 55,000 15,000
Deferred clearing credit 971,000 138,000
Other 79,000 121,000
Total Liabilities 20,261,000 13,714,000
Stockholders’ Equity
Preferred stock, $0.01 par value, 10,000,000 shares authorized; none outstanding
Common stock $0.02 par value, 150,000,000 shares authorized; 124,454,783 issued and
outstanding at September 30, 2014 and 100,580,203 shares issued and outstanding at September 30, 2013
2,490,000 2,012,000
Additional paid-in-capital 77,596,000 67,982,000
Accumulated deficit (35,569,000) (54,212,000)
Total National Holdings Corporation Stockholders’ Equity 44,517,000 15,782,000
Non-Controlling interest 15,000 15,000
Total Stockholders’ Equity 44,532,000 15,797,000
Total Liabilities and Stockholders’ Equity $ 64,793,000 $ 29,511,000
NATIONAL HOLDINGS CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
Years Ended September 30,
2014 2013
Revenues
Commissions $ 114,301,000 $ 78,168,000
Net dealer inventory gains 16,482,000 13,426,000
Investment banking 19,035,000 14,002,000
Investment advisory 14,161,000 9,508,000
Interest and dividends 3,541,000 3,935,000
Transfer fees and clearing services 8,676,000 7,740,000
Tax preparation and accounting 7,811,000 -
Other 285,000 804,000
Total Revenues 184,292,000 127,583,000
Operating Expenses
Commissions, compensation and fees 152,145,000 109,563,000
Clearing fees 3,701,000 2,840,000
Communications 4,772,000 4,494,000
Occupancy 4,056,000 2,070,000
Licenses and registration 1,620,000 1,483,000
Professional fees 4,099,000 2,642,000
Interest 33,000 248,000
Depreciation and amortization 1,136,000 926,000
Other administrative expenses 4,908,000 1,530,000
Total Operating Expenses 176,470,000 125,796,000
Income from Operations 7,822,000 1,787,000
Other Expense
Loss on investment in unaffiliated entity - (162,000)
Total Other expense - (162,000)
Income before income taxes $ 7,822,000 $ 1,625,000
Income tax (benefit) expense (Note 13) (10,821,000 ) 60,000
Net Income 18,643,000 1,562,000
Net loss attributable to non-controlling interest - 3,000
NET INCOME ATTRIBUTABLE TO NATIONAL HOLDINGS CORPORATION $ 18,643,000 $ 1,565,000
Net income per share of common stock attributable to National Holdings Corporation - Basic $ 0.15 $ 0.02
Net income per share of common stock attributable to National Holdings Corporation - Diluted $ 0.15 $ 0.02
Weighted average number of shares outstanding - Basic 123,026,480 70,651,415
Weighted average number of shares outstanding – Diluted 123,888,863 74,887,749
Non-GAAP Financial Measures
To provide investors with greater insight, promote transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making, the Company supplements its consolidated statements of income presented on a GAAP basis with non-GAAP financial measures of earnings. Please refer to the schedule in this release for a reconciliation of non-GAAP financial measures to GAAP measures.
Management uses Earnings before Interest, Income Taxes, Depreciation and Amortization (“EBITDA”) and adjusted EBITDA as financial measures to evaluate the profitability and efficiency of the Company’s business model. EBITDA and adjusted EBITDA are not presented in accordance with GAAP.
Investors should consider the non-GAAP measures in addition to, and not as a substitute for, financial measures prepared in accordance with GAAP. Additionally, the Company’s non-GAAP measures may differ from similar measures used by other companies, even if similar terms are used to identify such measures.
National Holdings Corporation
Reconciliation of Non-GAAP Financial Measures to GAAP Measures
Fiscal Year Ended
2014 2013
Net income, as reported $ 18,643,000 $ 1,565,000
Interest expense 33,000 248,000
Income taxes (10,821,000) 60,000
Depreciation and amortization 1,136,000 926,000
EBITDA 8,991,000 2,799,000
Non-cash compensation expense 1,124,000 379,000
Forgivable loan amortization 243,000 349,000
Loss on investment in unaffiliated entity - 162,000
Non-cash settlement costs - 313,000
EBITDA, as adjusted $ 10,358,000 $ 4,002,000
*revised from $4,103,000 due to a reclassification of certain taxes that
should not have been included in Income taxes.
National Holdings Corporation
Robert Fagenson, 212-417-8210
Or
Prosek Partners
Nick Rust, 212-279-3115
nrust@prosek.com
MAUXF..$0.476.. Sold a few more above $0.48 but the bids have yet to exceed my initial sales at $0.468.. 59 K to go.. hank
MAUXF.... $0.492.. Took some more off the table.. Made 18% on a larger part of yesterday's trade.. I think MAUXF is not quite a buy and hold at this or any level above $0.25.. I will continue to trade it building a position along the way.. still holding 65K at an AVE. of $0.436.. Offering more @0.485.. I just don't see much of a bounce back ability from here.. hank
DGPIF.. $0.461.. Added again today.. Looks like I'm the only USD buyer..?? hank
MAUXF.... $0.468.. Took some off the table.. Made 14% on a small part of yesterday's trade.. I think MAUXF is not quite a buy and hold at this or any level above $0.25.. I will continue to trade it building a position along the way.. hank
TLGN.. $0.20.. Little company.. Has a unique product that seems to having the beginnings of acceptance.. It's more of a stocking stuffer than a real investment.. I have bought a few.. hank
Contact Info
1947 Leslie St.
Toronto, ONT M3B 2M3
Canada
Website: http://www.totallygreen.com
Phone: 855-355-6722
Email: ir@totallygreen.com
Business Description
T: Totally Green, Inc. develops and markets the company's ORCA Green Machine. The ORCA (Organic Refuse Conversion Alternative) machine allows for rapid composting of most organic material in institutional and commercial end-user applications, after which the liquid compost is disposed of through the ordinary sewer system. The machine creates meaningful cost savings for customers while diverting food waste from landfills and reducing methane gas production. For more information, please visit www.totallygreen.com.
ABOUT ORCA
The ORCA system offers the most environmentally friendly organic food waste disposal solution. With our on site waste digestion equipment, customers are able to dispose of organics at the source, eliminating the need to truck the waste to landfills or remote composting facilities. Our digestion process is able to convert over one ton of organic waste into environmentally safe water within a 24 hour period.
Financial Reporting/Disclosure
Reporting Status Alternative Reporting Standard
Audited Financials Audited
Latest Report Sep 30, 2014 Quarterly Report
CIK 0001411165
Fiscal Year End 12/31
OTC Marketplace OTC Pink Limited
Profile Data
SIC - Industry Classification
Incorporated In: NV, USA
Year of Inc. Not Available
Employees 2002 a/o Aug 31, 2007
Company Officers/Contacts
Shawn Dym President
James Nakai Controller
Matt Shalhoub Gen. Manager
Company Directors
Not Available
Company Notes
•Formerly=Naturally Iowa, Inc. until 11-2010
•Formerly=Cheflive, Inc. until 8-07
Service Providers
Accounting/Auditing Firm
Grant Thornton LLP
1401 Scotia Place 2
10060 Jasper Avenue N.W
ALB, T5J 3R8
Canada
Legal Counsel
Carter Ledyard & Milburn LLP
Two Wall Street
New York, NY, 10005
United States
DGIPF.. $$0.435.. Up over 10% since the first and I just got tired chasing it.. Looks like a nice position trading stock.. It's real thin and has precived value by most.. Time will tell but below is the post that got my opinion.. I will have to say their web site doesn't give much in the way of information so I'm relieying on others on this one.. hank
Nice Company ,, worth the time to DD.. hank
From another posters view..
SSKILLZ1 Member Level Sunday, 01/04/15 12:41:01 PM
Re: None
Post # of 7019
DGI.TO (DGPIF)
I've been buying DGI.TO (sub .40 USD) over the last month for me this is a Table Pounder, and my best idea for 2015. We will see how it does. My DD is below.
Business Services
This is the stock I have been buying the whole month of December, and even brought a little on Friday. It is 6% of my personal portfolio which for me is a huge position as this is my top pick of 2015. Here is what I like.
Turnaround Play- DGI.TO is a turnaround play that is based on threefold approach, revenue stabilization and then growth, cutting costs and making themselves far more efficient and profitable, and reducing debt. The Next question is how are they doing?
Revenues: have stabilized in fact last quarter was the first quarter where they showed revenue growth in a while, I expect the stabilization/Growth to continue in my opinion. They have won a lot of new business to increase revs which is very positive in my opinion.
Cutting Costs: They have taken a ton of overhead out of the business. In fact they are consolidating 4 facilities, to 1 state of the art facility in q1 of 2015, that is expect to save 2.5-3 Million annually, we are talking about adding about .08 -.10 after tax eps to the bottom line next year on this alone.
Reducing Debt: Since 2013 they have reduced long-term debt by approximately 10 Million and Paid down the bank loan by 2 million just this quarter alone. I expect debt to continue to be reduced and handled by the enormous bottom line profits we are seeing.
Q3 and 9 Months Ended
The company reported 5.4% y/y revenue growth, and .08 eps. And for Nine Months ended we have seen .12 EPS. If we ex out restructuring costs (which I believe we should) we are looking at .09 and .19 for 3 and 9 months respectively.
Q4 and the Look Ahead
In the q3 CC, when asked about q4. They said they were optimistic it would be the best quarter of the year. I expect .10-.15 in q4 (Ignoring restructuring expenses).
As for next year I expect revs to be in line to slightly up next year, so I expect .40-.50 (Ignoring restructuring expenses)
Valuation
If my 2015 estimates are correct the stock will be trading at a PE of roughly 1. Now I realize there are concerns and I will address them in a bit But I don’t see why this stock can’t get a 3-5 PE rather easily, will increase the current share price by 200-400% if my numbers are proven to be correct, in my opinion there is no stock with higher upside potential then DGI.TO at this point in the market right now.
The Concerns
Balance sheet is admittingly weak, but there earnings should be easily enough to support and continue to reduce their debt levels in my opinion.
The second concern is should we ex out the never ending restructuring expenses. I believe we should, and I believe these restructuring expenses should be exed out because they are actually showing that there is a result, these expense have clearly led to reducing unnecessary overhead on both the square footage and personal side reflected into lower operating expenses. Also it is important to note restructuring expenses have been dropping y/y, I expect that to continue as more of the cost savings plan is realized and is behind them. q1 will should see a rise because a specific event that is gonna be long term helpful on both the cost side, and the efficiency side of the business.
Why the stock price is at lower levels? Well I believe Tax loss selling was a huge reason, as I said many times when a company is at its lows at and has a good November quarter it has 0 Value to the stock price during that year. Having said that it is now 2015, that is behind us now and as this exciting turnaround/absurdly cheap Valuation story comes to light I expect people will get excited, because there is a lot to get excited about here, as it might be the cheapest stock I have ever seen.
Why am I Table Pounding on DGI.TO (DGPIF)? I think DGI.TO is one of the cheapest stocks I have ever seen, I admit there are some warts, but the stock is priced for unmitigated disaster anything better should cause the stock to double, triple or even more in 2015.
Conclusion: I think DGI.TO (DGPIF) is absurdly undervalued, and now that we are finally starting to see some revenue growth, along with additional cost saving that will be very helpful to increasing the bottom line in 2015. All is just my opinion, and I could always be wrong though.
MAUXF $0.429,, Bought a bunch more today @$0.41.. The story below is telltale of what is happening around the world and bodes well for current producers.. MAUXF is a hold your nose type of investment but on production numbers a steal..
Bankers see $1trn of zombie investments stranded in oil fields
January 6, 2015 | Filed under: Banking,Breaking News,Company News | Author: Editor
After crude prices dropped 49 percent in six months, oil projects planned for next year are the undead – still standing upright, but with little hope of a productive future. These zombie projects proliferate in expensive Arctic oil, deepwater-drilling regions and tar sands from Canada to Venezuela.
In a stunning analysis, Goldman Sachs found almost $1 trillion in investments in future oil projects at risk. They looked at 400 of the world’s largest new oil and gas fields – excluding US shale – and found projects representing $930 billion of future investment that are no longer profitable with Brent crude at $70. In the US, the shale-oil party isn’t over yet, but zombies are beginning to crash it.
If the unprofitable projects were scuttled, it would mean a loss of 7.5 million barrels per day of production in 2025, equivalent to 8 percent of current global demand.
It is not clear yet how far OPEC is willing to let prices slide.
The UAE’s energy minister said on December 14 that OPEC wouldn’t trim production even if prices fall to $40 a barrel.
An all-out price war could take up to 18 months to play out, said Kevin Book, managing director at ClearView Energy Partners LLC, a financial research group in Washington.
If cheap oil continues, it could be a major setback for the US oil boom.
The Goldman tally takes the long view of project finance as it plays out over the next decade or more. But the initial impact of low prices may be swift.
In 2015 year alone, oil and gas companies will make final investment decisions on 800 projects worth $500 billion, said Lars Eirik Nicolaisen, a partner at Oslo-based Rystad Energy.
If the price of oil averages $70 in 2015, he wrote, $150 billion will be pulled from oil and gas exploration around the world.
An oil price of $65 a barrel would trigger the biggest drop in project finance in decades, according to a Sanford C. Bernstein analysis.
KLYG.. $0.073 I spoke to the New PR guy who was actually aboard when KLYG traded above a Buck and he said that the tech and expertise was the reason for them buying another company.. I don't remember the 8K saying anything about sales.. I've followed KLYG for over 4 years now and they have rarely done anything to surprise me.. It is a small company and sales can vary a great deal on a few difference in the number of products being sold..
If you search Hank's Trading over the years you will find much Info not else where kept.. I believe that thier Implant's are finally gaining a grip on the market and that is thier reason to hire a PR firm.. Give him a call and he will cheer you up on any bad day in the market.. BTW I able to add 90,000 @0.07 Just before Xmas.. I think after the end of first Qtr. we could see $0.15 or higher.. Stockholders equity increased another 8% during the past qtr..
KLYG..$0.073
Statement of Income
For the 2nd and 3rd Quarter Ended September 30, 2014
KELYNIAM GLOBAL, INC.
June 30, 2014,, September 30, 2014,, Year to Date
Sales $436,865 $455,401 $1,432,552
Cost of Sales 222,138 172,674 665,310
Gross Profit 214,727 282,727 767,242
General and administrative expenses 221,070 210,427 649,445
Income from Operations (6,343) 72,300 117,797
Other Income
Interest income 2 2 8
Net Income (6,341) 72,302 117,805
www.kelyniam.com
STOCKHOLDERS’ EQUITY
Common stock, $.001 par value, 60,000,000 shares authorized,
19,526,800 shares issued, 19,526,800 outstanding 19,017 19,017
Additional paid-in capital 2,436,564 2,436,564
Retained earnings (Deficit) (1,697,763) (1,654,001)
Total stockholders’ equity 757,818 801,580
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $1,444,223 $1,452,852
KELYNIAM GLOBAL, INC.
Internally produced by Kelyniam - these financials have not been reviewed, audited, or compiled.
BALANCE SHEET
June 30, 2014
September 30, 2014
ASSETS
CURRENT ASSETS
Cash $63,599 $75,138
Accounts receivable 212,235 286,855
Inventory 54,576 16,632
Prepaid rent 3,752
Investment securities available for sale 160,777 131,455
Total current assets $491,187 $513,832
CAPITAL ASSETS
Manufacturing Equipment 359,582 359,582
Computer Equipment 24,982 24,982
Furniture and Fixtures 8,043 8,043
Leasehold Improvments 189,455 189,455
582,062 582,062
Less accumulated depreciation (322,483) (335,735)
Total capital assests 259,579 246,327
OTHER ASSETS
License, net of accumulated amortization of $9,930 35,139
License, net of accumulated amortization of $11,458 34,375
Security Deposit 8,000 8,000
Deferred income tax asset 650,318 650,318
Total other assets 693,457 692,693
TOTAL ASSETS $1,444,223 $1,452,852
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Notes payable $78,125 $63,750
Line of Credit - Bank 165,623 165,623
Credit cards payable 987
Commissions payable 47,245 35,150
Accrued expenses 64,293 74,630
Accrued interest 9,803 6,291
Current portion of capital leases 9,282 30,674
Current portion of long-term debt 30,238 26,880
Total current liabilities $405,596 $402,998
LONG-TERM DEBT
Long-term debt, less current portion 229,464 222,809
Capital lease obligations, less current portion 51,345 25,465
Total long-term debt 280,809 248,274
STOCKHOLDERS’ EQUITY
Common stock, $.001 par value, 60,000,000 shares authorized,
19,526,800 shares issued, 19,526,800 outstanding 19,017 19,017
Additional paid-in capital 2,436,564 2,436,564
Retained earnings (Deficit) (1,697,763) (1,654,001)
Total stockholders’ equity 757,818 801,580
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $1,444,223 $1,452,852
$ORBC..Sierra Nevada hands off..The first six satellites of a 17-satellite ORBCOMM Generation Two (OG2) constellation designed and built by Sierra Nevada Corporation’s Space Systems based in Louisville have completed all on-orbit checkout procedures and have been transferred to ORBCOMM, SNC announced.
http://www.digitalcolorado.co/articles/397651/sierra-nevada-hands-off-first-6-of-17-new-satellit/
Merry Christmas to you too Hank...safe travels and a Happy New Year.
Today I head back north for the Holidays.. Merry Xmas and a happy New Years to all.. hank
ERLIF.. $0.085 Table Pounder.. New Insider Buying... This is not a small company,, I think the selling has come from Canadian Margin Calls because of Energy and Mining stocks market driving all Canadian Stocks down.. .. hank
http://www.baystreet.ca/articles/research_reports/eresearch/EIL_120814-B.pdf
KLYG.. $0.07..
Kelyniam Global Announces Q2 and Q3 Earnings
Canton, CT, December 06, 2014 --(PR.com)-- Kelyniam Global, Inc. (OTC Pink: KLYG), an innovative medical device design and manufacturing company, posted its 2nd & 3rd quarter sales at $436,865 and $455,401 respectively. The reduction in quarterly revenue can be directly attributed to company resources allocated to its recent acquisition of MED-ALLY, LLC and the development and implementation of enhanced efficiency processes now being used in the manufacturing of PEEK Optima cranial and cranial-facial implants. These manufacturing efficiencies substantially reduce materials usage and associated costs, which increases profit margins and company bottom line.
"This year has been a building and development year for Kelyniam. We have had to allocate some of our human resources to our goal of product diversification and expansion, but strongly believe these efforts are in the best interest of the company long term and will have significant effects on the overall value of Kelyniam Global, Inc.,” said Tennyson Anthony, president and CEO of Kelyniam Global. “With the acquisition of MED-ALLY, we have opened the door to being a leader in the neurostimulation field which is the most promising and exciting field in medicine today. There is incredible potential here and we are working to capitalize on that potential and realize a position at the top.” For more information go to www.kelyniam.com
About Kelyniam Global, Incorporated
Kelyniam Global (OTC: KLYG) is an innovative Medical Device Manufacturing Company specializing in the production of custom PEEK cranial and facial prosthetics and proprietary, implantable neuromodulation medical device systems. Its Engineering Division works diligently with medical professionals - allowing them to operate more effectively, improve patient care and surgical outcomes while reducing health care cost. Kelyniam is continually researching and developing new products, materials and processes to help patients live more active and productive lives.
Forward-Looking Statements
Except for historical information contained in this release, the matters discussed are forward-looking statements that involve risks and uncertainties. When used in this release, words such as "anticipate," "believes," "estimate," "expect," "should," "intend," "projects," "objective" and "appears" and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the impact of competitive products and pricing; capacity and supply constraints or difficulties; product development, commercialization or technological difficulties; the regulatory and trade environment; the impact of reimbursement rates and coverage; and the risk factors reported from time to time in the Company's SEC reports. The Company undertakes no obligation to revise any forward-looking statements as a result of future events or developments.
Contact:
Christian Scarborough, www.inventivepr.net
christian@inventivepr.net
325-388-6263
Contact Information
Kelyniam Global, LLC
Christian Scarborough
325-388-6263
Contact
www.kelyniam.com
ERILF.. $0.092 Nice numbers,, Increased backlog..
Empire Industries Reports Third Quarter Results
WINNIPEG, MANITOBA--(Marketwired - Nov 27, 2014) - Empire Industries Ltd. (TSX VENTURE:EIL) today reported its unaudited consolidated financial results for the third quarter ended September 30, 2014. The unaudited consolidated financial statements and MD&A have been filed on SEDAR and can be viewed at www.sedar.com or at www.empind.com.
Summary of Third Quarter 2014 results
•Revenues increased by $2.4 million, or 7% (to $36.5 million from $34.1 million in third quarter 2013).
•Adjusted EBITDA increased by $0.2 million or 9.5% to $2.3 million.
•Net Income decreased by $0.9 million (to $0.7 million from 1.6 million in third quarter 2013).
•Net Income per share remained constant at $0.005 per share.
•Contract Backlog remains strong at $93 million, down from $123 million at of the Group's first quarter report due to project execution.
For the quarter and nine month periods ended Sept 30
($ millions except share price and per share amounts) Q3
2014 Q3
2013 YTD
2014 YTD
2013
Financial Results
Revenue 36.5 34.1 105.0 86.3
Adjusted EBITDA ($)1 2.3 2.1 6.2 5.1
Adjusted EBIT ($)1 1.8 1.8 5.0 2.6
Net income from all operations 0.7 1.6 3.6 3.7
Financial Position (at Sept 30)
Total assets 62.7 39.7 62.7 39.7
Long-term debt (including current portion) 3.1 0.2 3.1 0.2
Shareholders' equity 19.1 13.8 19.1 13.8
Per Share Information
Income per share (Basic) 0.005 0.005 0.015 0.015
Income per share (Diluted) 0.005 0.005 0.015 0.015
1 Adjusted earnings (loss) before interest, tax, depreciation and amortization (Adjusted EBITDA) is not defined by IFRS. The definition of Adjusted EBITDA does not take into account the Group's share of profit of an associate investment, gains and losses on the disposal of assets, fair value changes in foreign currency forward contracts and non-cash components of stock based compensation. Adjusted EBIT is the result of the Group's Adjusted EBITDA less depreciation and amortization expenses. While not IFRS measures, Adjusted EBITDA and Adjusted EBIT are used by management, creditors, analysts, investors and other financial stakeholders to assess the Group's performance and management from a financial and operational perspective.
"I am pleased to report that the company continued to improve its bottom line and strengthen its balance sheet," said Guy Nelson, Chief Executive Officer of Empire Industries Ltd. "The diversity of our business made this happen as gains in steel fabrication and hydrovac truck manufacturing offset reductions in media based attractions and our commitment to invest in our industry leading, new product development."
About Empire Industries Ltd.
Empire Industries Ltd. manufactures specialized engineered products and sells these products domestically and in select international export markets. The company has developed, designed and engineered products for the rapidly growing, global, media based attractions market. The company also provides steel fabrication & installation services, primarily to the industrial, commercial and infrastructure market in Western Canada. The company also has two key strategic equity partnerships; a 49% ownership of ACE Industrial Services that operates in the oil sands industrial maintenance services market, and a 45% ownership of a Chinese joint venture company in the steel fabrication market in Asia. Empire's common shares are listed on the TSX Venture Exchange under the symbol EIL.
For more information about the Company, visit www.empind.com.
MNDO. $4.10... Sold out of MNDO today.. Nice run,, thanks to HWEB on this one.. hank
CCNI.. $0.835.. Have been adding almost daily.. hank
MEDD.. $0.07.. I saw this release a month ago and have been on the bid since.. Since it trade thin and few shares have come in I bought a few today at the offer.. The funding and ownership of 2 more imaging centers will triple Medds's revenues and should INCREASE Medd's cash flow parabolic.. I think it is a speculation worth owning.. If anyone has had an MRI lately one would know the overbooking of each facility and even open on weekend in most places.. hank
On October 31, 2014, Medical Imaging Corp. (the “Company”) sold to Grenville Strategic Royalty Corp. (“Holder”) a gross royalty on the revenues of the Company (the “Royalty”) for the principal amount of $2,000,000. The Royalty requires a monthly payment equal to a specified percentage of the Company’s revenue for the previous month, subject to certain minimum payments. The Holder has an option, but no obligation, to purchase one or more additional Royalties from the Company, subject to the Company’s approval, for up to an additional $1,000,000, which would increase the royalty payments proportionately.
Proceeds from the Royalty were used primarily to finance the acquisition entered into by the Company on August 28, 2014 (see Item 2.01 below) with the remainder as for general working capital purposes.
Item 2.01 Completion of Acquisition or Disposition of Assets.
On October 31st, 2014 the Company completed acquisitions of three separate facilities located in the Venice, Port Charlotte and Naples, Florida areas (as announced on September 2, 2014). The acquisitions were made in each instance by acquiring the limited liability company which owned the physical assets of the facilities, consisting principally of the imaging related equipment, and the facility leases. Separately, the Company engaged operating personnel for each facility, which are both direct employees and contract personnel. Day to day operations will be handled by managerial and dedicated staff at each facility, however, billing and certain other operational activities will be centralized at the Company’s Dallas, Texas office. Because the facilities are located in separate communities, each facility will draw upon its current and expand its own regional base of referral physicians and patients. The Company has obtained for each facility a separate Medicare billing number to enable each facility and subsidiary of the Company to bill separately. Each facility also will establish its own contracts with various private insurance payors.
Each of the facilities provides a different range of services. Partners Imaging of Naples provides MRI and CT services. Partners Imaging of Port Charlotte provides MRI services. Partners Imaging of Venice provides MRI, CT, PET, X-ray and Ultrasound services.
The aggregate acquisition price was $1.8 million, for all the outstanding membership interests of each of the three limited liability companies acquired.
Due to the relative size of each of the acquisitions to the Company as a whole, financial statements are not being presented in this 8-K report.
=====================================================
Medical Imaging Corp., is a public company trading on the OTCQB under the stock symbol MEDD. The Company is focussed on acquiring medical imaging businesses that demonstrate a stable financial history.
Through its operating subsidiaries, Medical Imaging Corp. provides imaging services that include MRI, CT, and X-ray for in clinic scans and radiology reports, as well as remote radiology services for rural hospitals.
Focused on community building, MEDD works with local healthcare practitioners to ensure we are meeting the demands of today's patients. We pride ourselves on an ability to be flexible, modern, competitive, and professional at every facet of our business.
With additional acquisitions, Medical Imaging Corp., will look to create opportunities to increase revenue and EBITDA. We will nurture existing business while seeking out ways to streamline costs companywide.
data:image/jpeg;base64,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
http://www.oil-price.net/
x1512g Filings - http://1512g.com/
American Stock Exchange - http://www.nyse.com/attachment/amex_landing.htm
Authorized Shares for Nevada and Other States - http://www.authorized-shares.com/
Barrons - http://online.barrons.com/public/main
BioHealth - http://www.biohealthinvestor.com/
BioMed - http://biomedreports.com/
BioSpace - http://www.biospace.com/
Bloomberg - http://www.bloomberg.com
Business News - http://www.bloomberg.com
Business News - http://www.reuters.com/finance/markets
Business News Portal - http://www.businesswire.com/portal/site/home/
BusinessWeek - http://www.businessweek.com/
Candlesticks - www.candlesticker.com/Default.asp
Chart Analysis - www.stockcharts.com/school/doku.php
Chart Video Lessons - http://investorshub.advfn.com/boards/read_msg.aspx?message_id=46647251
Charts - http://bigcharts.marketwatch.com/avatar.asp
Charts - http://chartpatterns.com/
Charts - http://stockcharts.com/
Charts - http://www.incrediblecharts.com/technical/candlesticks.htm
China Business News - http://www.chinadaily.com.cn/bizchina/index.html
China Business News - http://www.xinhuanet.com/english2010/business/index.htm
China Technology News - http://www.chinatechnews.com/
Clinical Trials - http://www.clinicaltrials.gov/
CNBC - http://www.cnbc.com
CNNMoney.com - http://www.money.cnn.com/
Corporate Bankruptcy - http://www.sec.gov/investor/pubs/bankrupt.htm
Corporate Records Search - http://www.coordinatedlegal.com/SecretaryOfState.html
Corporate Records Search - http://www.searchsystems.net/list.php?nid=398
CUSIP number - http://activequote.fidelity.com/mmnet/SymLookup.phtml
DD Amanda - http://ddamanda.com/Members/AmandaChartStart.php
DD Machine - http://www.ddmachine.com/
Deregistering - http://www.aaii.com/commentary/articles/200601_stockstrategies.cfm
Dividends - http://www.dividenddetective.com/
Document Research - http://www.10kwizard.com/main.php
Earnings - http://www.earningswhispers.com/calendar.asp
Education - http://www.investopedia.com/?viewed=1
Email Address Verifier - http://verify-email.org/
EYE ON THE FDA - http://www.eyeonfda.com/
FINRA Daily Short List - www.regsho.finra.org/regsho-Index.html
Floats - http://investorshub.advfn.com/boards/board.aspx?board_id=15223
Fool.com - http://www.fool.com
Forbes - http://www.forbes.com/home_usa
Form 4 Filings - http://www.secform4.com/index.php
Google News Business - http://news.google.com/?ned=us&topic=b
Google News Home - http://news.google.com/
Holiday Schedule for Stock Markets - http://www.allstocks.com/html/stock_markets_holidays.html
High Short Interest Stocks - http://www.highshortinterest.com/
Insider Buy & Sell Info - http://www.insidercow.com/latestFillings/buyByCompany.jsp;jsessionid=00CD11F05D6090BBECE249167FD45A5B
Investing Glossary - http://www.investorwords.com/
Investopedia - http://www.investopedia.com/?viewed=1
Investors Business Daily - http://www.investors.com
Investor Words - http://www.investorwords.com/
Knobias - http://www.knobias.com/individual/public/quote.htm
Level 2 Video Tutorial - http://stockhideout.com/images/flash/level.html
Low Float Stocks - http://www.lowfloat.com/
MarketWatch.com - http://www.marketwatch.com/
Message, Blog & Twitter Postings - http://www.thelion.com
MicrocapMarkets NASDAQ <$5 - http://www.microcapmarkets.com/data_main_nav.jsp?market=NASDAQ
MicrocapMarkets OTCBB - http://www.microcapmarkets.com/data_main_nav.jsp?market=OTCBB
Mining - http://www.miningmx.com/
MSN Money Central - http://www.moneycentral.msn.com/investor/home.asp
Multicollinearity - www.stockcharts.com/help/doku.php
Mutual Fund Facts About Individual Stocks - http://www.mffais.com/
Naked Shorting - www.businessjive.com/
NASDAQ Stock Market - http://www.nasdaq.com/
NASDAQ/NYSE/AMEX Stock Info - www.secfilings.com/
Natural Resources News & Commentary - http://www.resourceinvestor.com/Pages/default.aspx
New York Stock Exchange - http://www.nyse.com/home.html
OTCBB Daily List - http://www.otcbb.com/dailylist/
Patterns - http://thepatternsite.com/
Pinksheets Stock Info - www.otcmarkets.com/pink/index.jsp
Platform - http://www.quotetracker.com/
Precious Metals - http://www.kitco.com/
Press Releases - http://www.prnewswire.com/news-releases/
REG SHO List - www.regsho.com/tools/short_list.php
Regional Bank List - http://www.bullsector.com/regionalbanks.html
Reverse Phone & Address - http://www.whitepages.com/reverse-lookup
Reverse Mergers - http://www.gopublic.com/reversemerger.html
Reverse Merger Report - http://reversemerger.dealflowmedia.com
Reverse Splits - http://investorshub.advfn.com/boards/board.aspx?board_id=3017
Screener - http://clearstation.com
Screener - http://smallcapcenter.com
Searching Blogs, News, etc. - http://www.icerocket.com/
SEC - http://www.sec.gov
SEC Filings - http://www.edgar-online.com/
SEC Filings - http://www.sec.gov/edgar/searchedgar/companysearch.html
SEC Filings - http://www.secinfo.com
SEC Form Types and Definitions - http://learn.westlawbusiness.com/support/formtypes.html
Secretary of State Sites - All states: http://www.coordinatedlegal.com/SecretaryOfState.html
Seeking Alpha BioTech Stocks - http://www.seekingalpha.com/sector/biotech
Shell Stocks - http://www.shellstockreview.com
SHO Threshold List - http://www.nasdaqtrader.com/Trader.aspx?id=RegSHOThreshold
Short Stocks - http://shortsqueeze.com/
Stock Chart Patterns - www.trending123.com/patterns/index.html
Stock Promotions - www.stockpromoters.com
Stock Promotions - www.stockreads.com/
Stock Research - http://www.stockhouse.com
Stock Scanning - http://bigcharts.marketwatch.com/markets/screener.asp?exchange=118&screen=1&x=15&y=18
Stock Scanning - http://clearstation.etrade.com/cgi-bin/events?Cmd=techev
Stock Scanning - http://markets.usatoday.com/custom/usatoday-com/screener/screener.asp
Stock Scanning - http://screen.yahoo.com/stocks.html
Stock Scanning - http://stockcharts.com/def/servlet/SC.scan
Stock Scanning - http://www.acmechart.com/
Stock Scanning - http://www.americanbulls.com/
Stock Scanning - http://www.barchart.com/
Stock Scanning - http://www.prophet.net/scans/index.jsp
Stock Scanning - http://www.smallcapcenter.com/tools_technicalSearch.asp?page=ANALYTICSSEARCH_IN.ASP
Stock Scanning - http://www.stockciphering.com/index.htm
Stock Scanning - http://www.stockfetcher.com/
Stock Scanning - http://www.stockscores.com/index.asp
Stock Scanning - http://www.stockworm.com/help/tours/stock-screener.html;jsessionid=aEg_MdzO2SH9
Stock Scanning - http://www2.barchart.com/
Technical Analysis - http://stockta.com/
Technical Indicators/Overlays - www.stockcharts.com/school/doku.php
TheStreet.Com - http://www.thestreet.com/
Trading Halts - http://www.nasdaqtrader.com/Trader.aspx?id=TradeHalts
Trading Platform - www.equityfeed.com
Trading Stations - http://www.tradingcomputers.com/index.html
Transfer Agent Contact Information - http://investorshub.advfn.com/boards/board.aspx?board_id=10067
Transfer Agents in the United States - http://www.stocktransfer.com/index.cfm?action=about.network.transferAgents
Translation Tool - http://www.verbatimsolutions.com/freetranslation.php
USAToday Business - http://markets.usatoday.com/custom/usatoday-com/html-markets.asp
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |